SIMILAR PATTERNS OF AMINO ACIDS FOR 3JYR_A_ACRA371

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hsj FUSION PROTEIN
CONSISTING OF
STAPHYLOCOCCUS
ACCESSORY REGULATOR
PROTEIN R AND
MALTOSE BINDING
PROTEIN

(Escherichia
coli;
Staphylococcus
aureus) 		PF01547
(SBP_bac_1) 		10 ASP A  14
LYS A  15
LYS A  42
GLU A  44
GLU A  45
ALA A  63
ASP A  65
ARG A  66
GLU A 111
TRP A 230
 GLC  A 672 (-3.0A)
GLC  A 672 (-2.3A)
None
None
None
GLC  A 671 ( 3.2A)
GLC  A 671 (-2.8A)
GLC  A 671 (-3.6A)
GLC  A 672 (-2.7A)
GLC  A 672 (-4.2A)
 0.81A 3jyrA-1hsjA:
61.1		 3jyrA-1hsjA:
87.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hsj FUSION PROTEIN
CONSISTING OF
STAPHYLOCOCCUS
ACCESSORY REGULATOR
PROTEIN R AND
MALTOSE BINDING
PROTEIN

(Escherichia
coli;
Staphylococcus
aureus) 		PF01547
(SBP_bac_1) 		10 ASP A  14
LYS A  15
LYS A  42
GLU A  44
GLU A  45
ALA A  63
ASP A  65
GLU A 111
PRO A 154
TRP A 230
 GLC  A 672 (-3.0A)
GLC  A 672 (-2.3A)
None
None
None
GLC  A 671 ( 3.2A)
GLC  A 671 (-2.8A)
GLC  A 672 (-2.7A)
GLC  A 671 (-3.1A)
GLC  A 672 (-4.2A)
 0.61A 3jyrA-1hsjA:
61.1		 3jyrA-1hsjA:
87.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hsj FUSION PROTEIN
CONSISTING OF
STAPHYLOCOCCUS
ACCESSORY REGULATOR
PROTEIN R AND
MALTOSE BINDING
PROTEIN

(Escherichia
coli;
Staphylococcus
aureus) 		PF01547
(SBP_bac_1) 		9 LYS A  42
GLU A  44
GLU A  45
ALA A  63
ASP A  65
ARG A  66
GLU A 111
TRP A 230
TYR A 341
 None
None
None
GLC  A 671 ( 3.2A)
GLC  A 671 (-2.8A)
GLC  A 671 (-3.6A)
GLC  A 672 (-2.7A)
GLC  A 672 (-4.2A)
None
 0.93A 3jyrA-1hsjA:
61.1		 3jyrA-1hsjA:
87.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hsj FUSION PROTEIN
CONSISTING OF
STAPHYLOCOCCUS
ACCESSORY REGULATOR
PROTEIN R AND
MALTOSE BINDING
PROTEIN

(Escherichia
coli;
Staphylococcus
aureus) 		PF01547
(SBP_bac_1) 		9 LYS A  42
GLU A  44
GLU A  45
ALA A  63
ASP A  65
GLU A 111
PRO A 154
TRP A 230
TYR A 341
 None
None
None
GLC  A 671 ( 3.2A)
GLC  A 671 (-2.8A)
GLC  A 672 (-2.7A)
GLC  A 671 (-3.1A)
GLC  A 672 (-4.2A)
None
 0.71A 3jyrA-1hsjA:
61.1		 3jyrA-1hsjA:
87.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1mg1 PROTEIN (HTLV-1 GP21
ECTODOMAIN/MALTOSE-B
INDING PROTEIN
CHIMERA)

(Primate
T-lymphotropic
virus 1) 		PF00429
(TLV_coat)
PF13416
(SBP_bac_8) 		9 ASP A  15
LYS A  16
GLU A  45
GLU A  46
ALA A  64
ASP A  66
GLU A 112
PRO A 155
TRP A 231
 MAL  A 456 (-3.4A)
MAL  A 456 (-2.8A)
None
None
MAL  A 456 (-3.1A)
MAL  A 456 (-2.8A)
MAL  A 456 (-2.6A)
MAL  A 456 (-3.5A)
MAL  A 456 ( 4.8A)
 0.60A 3jyrA-1mg1A:
59.7		 3jyrA-1mg1A:
79.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1r6z CHIMERA OF
MALTOSE-BINDING
PERIPLASMIC PROTEIN
AND ARGONAUTE 2

(Drosophila
melanogaster;
Escherichia
coli) 		no annotation 10 ASP P  13
LYS P  14
LYS P  41
GLU P  43
GLU P  44
ALA P  62
ASP P  64
ARG P  65
GLU P 110
TRP P 229
 MAL  P 727 (-3.0A)
MAL  P 727 (-2.5A)
None
None
None
MAL  P 727 (-3.1A)
MAL  P 727 (-2.6A)
MAL  P 727 (-4.0A)
MAL  P 727 (-2.8A)
MAL  P 727 ( 4.7A)
 0.68A 3jyrA-1r6zP:
61.8		 3jyrA-1r6zP:
72.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1r6z CHIMERA OF
MALTOSE-BINDING
PERIPLASMIC PROTEIN
AND ARGONAUTE 2

(Drosophila
melanogaster;
Escherichia
coli) 		no annotation 10 ASP P  13
LYS P  14
LYS P  41
GLU P  43
GLU P  44
ALA P  62
ASP P  64
GLU P 110
PRO P 153
TRP P 229
 MAL  P 727 (-3.0A)
MAL  P 727 (-2.5A)
None
None
None
MAL  P 727 (-3.1A)
MAL  P 727 (-2.6A)
MAL  P 727 (-2.8A)
MAL  P 727 (-3.4A)
MAL  P 727 ( 4.7A)
 0.37A 3jyrA-1r6zP:
61.8		 3jyrA-1r6zP:
72.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1y4c MALTOSE BINDING
PROTEIN FUSED WITH
DESIGNED HELICAL
PROTEIN

(Escherichia
coli) 		PF13416
(SBP_bac_8) 		9 ASP A  14
LYS A  15
LYS A  42
GLU A  44
ALA A  63
ASP A  65
ARG A  66
GLU A 111
TRP A 230
 GLC  A 371 (-3.2A)
GLC  A 371 (-2.7A)
None
None
GLC  A 371 ( 3.2A)
GLC  A 372 (-2.8A)
GLC  A 372 (-3.8A)
GLC  A 371 (-2.9A)
GLC  A 371 ( 4.6A)
 0.77A 3jyrA-1y4cA:
62.4		 3jyrA-1y4cA:
70.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2vgq SUGAR ABC
TRANSPORTER
SUBSTRATE-BINDING
PROTEIN,MITOCHONDRIA
L
ANTIVIRAL-SIGNALING
PROTEIN

(Escherichia
coli;
Homo sapiens) 		PF13416
(SBP_bac_8)
PF16739
(CARD_2) 		12 ASP A  14
LYS A  15
LYS A  42
GLU A  44
GLU A  45
ALA A  63
ASP A  65
ARG A  66
GLU A 111
PRO A 154
TRP A 230
TYR A 341
 MTT  A1463 (-2.9A)
MTT  A1463 (-2.7A)
MTT  A1463 (-4.3A)
MTT  A1463 (-3.1A)
MTT  A1463 (-3.5A)
MTT  A1463 (-3.2A)
MTT  A1463 (-2.8A)
MTT  A1463 (-3.7A)
MTT  A1463 (-2.9A)
MTT  A1463 (-3.5A)
MTT  A1463 (-4.4A)
MTT  A1463 (-4.5A)
 0.23A 3jyrA-2vgqA:
63.1		 3jyrA-2vgqA:
79.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2xz3 MALTOSE ABC
TRANSPORTER
PERIPLASMIC PROTEIN,
ENVELOPE
GLYCOPROTEIN

(Bovine leukemia
virus;
Escherichia
coli) 		PF00429
(TLV_coat)
PF13416
(SBP_bac_8) 		9 ASP A  40
LYS A  41
GLU A  70
GLU A  71
ALA A  89
ASP A  91
ARG A  92
GLU A 137
TRP A 256
 MAL  A1488 (-3.0A)
MAL  A1488 (-2.5A)
None
None
MAL  A1488 (-3.2A)
MAL  A1488 (-2.8A)
MAL  A1488 (-3.8A)
MAL  A1488 (-2.9A)
MAL  A1488 (-4.5A)
 0.81A 3jyrA-2xz3A:
62.4		 3jyrA-2xz3A:
83.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2xz3 MALTOSE ABC
TRANSPORTER
PERIPLASMIC PROTEIN,
ENVELOPE
GLYCOPROTEIN

(Bovine leukemia
virus;
Escherichia
coli) 		PF00429
(TLV_coat)
PF13416
(SBP_bac_8) 		9 ASP A  40
LYS A  41
GLU A  70
GLU A  71
ALA A  89
ASP A  91
GLU A 137
PRO A 180
TRP A 256
 MAL  A1488 (-3.0A)
MAL  A1488 (-2.5A)
None
None
MAL  A1488 (-3.2A)
MAL  A1488 (-2.8A)
MAL  A1488 (-2.9A)
MAL  A1488 (-3.4A)
MAL  A1488 (-4.5A)
 0.56A 3jyrA-2xz3A:
62.4		 3jyrA-2xz3A:
83.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3a3c MALTOSE-BINDING
PERIPLASMIC PROTEIN,
LINKER,
MITOCHONDRIAL
INTERMEMBRANE SPACE
IMPORT AND ASSEMBLY
PROTEIN 40

(Escherichia
coli;
Saccharomyces
cerevisiae;
synthetic
construct) 		PF06747
(CHCH)
PF13416
(SBP_bac_8) 		9 ASP A  14
LYS A  15
GLU A  44
GLU A  45
ALA A  63
ASP A  65
GLU A 111
PRO A 154
TRP A 230
 MAL  A 466 (-4.3A)
MAL  A 466 (-3.2A)
None
None
MAL  A 466 (-3.1A)
MAL  A 466 (-2.7A)
MAL  A 466 (-3.1A)
MAL  A 466 (-3.6A)
MAL  A 466 (-3.7A)
 0.46A 3jyrA-3a3cA:
60.2		 3jyrA-3a3cA:
77.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3dm0 MALTOSE-BINDING
PERIPLASMIC PROTEIN
FUSED WITH RACK1

(Arabidopsis
thaliana;
Escherichia
coli) 		PF00400
(WD40)
PF01547
(SBP_bac_1) 		12 ASP A  14
LYS A  15
LYS A  42
GLU A  44
GLU A  45
ALA A  63
ASP A  65
ARG A  66
GLU A 111
PRO A 154
TRP A 230
TYR A 341
 GLC  A 672 (-3.1A)
GLC  A 672 (-2.4A)
None
EDO  A 401 (-3.7A)
EDO  A 401 ( 4.4A)
GLC  A 672 ( 3.2A)
GLC  A 671 (-2.8A)
EDO  A 401 ( 4.8A)
GLC  A 672 (-2.8A)
GLC  A 671 (-3.3A)
GLC  A 672 (-4.4A)
EDO  A 401 ( 4.5A)
 0.45A 3jyrA-3dm0A:
62.1		 3jyrA-3dm0A:
52.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ehs FUSION PROTEIN OF
CRFR1 EXTRACELLULAR
DOMAIN AND MBP

(Escherichia
coli;
Homo sapiens) 		PF02793
(HRM)
PF13416
(SBP_bac_8) 		9 ASP A-335
LYS A-334
GLU A-305
GLU A-304
ALA A-286
ASP A-284
ARG A-283
GLU A-238
TRP A-119
 MAL  A 126 (-2.9A)
MAL  A 126 (-2.7A)
None
None
MAL  A 126 (-3.1A)
MAL  A 126 (-2.8A)
MAL  A 126 (-4.0A)
MAL  A 126 (-2.6A)
MAL  A 126 ( 4.6A)
 0.67A 3jyrA-3ehsA:
61.2		 3jyrA-3ehsA:
72.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ehs FUSION PROTEIN OF
CRFR1 EXTRACELLULAR
DOMAIN AND MBP

(Escherichia
coli;
Homo sapiens) 		PF02793
(HRM)
PF13416
(SBP_bac_8) 		9 ASP A-335
LYS A-334
GLU A-305
GLU A-304
ALA A-286
ASP A-284
GLU A-238
PRO A-195
TRP A-119
 MAL  A 126 (-2.9A)
MAL  A 126 (-2.7A)
None
None
MAL  A 126 (-3.1A)
MAL  A 126 (-2.8A)
MAL  A 126 (-2.6A)
MAL  A 126 (-3.6A)
MAL  A 126 ( 4.6A)
 0.53A 3jyrA-3ehsA:
61.2		 3jyrA-3ehsA:
72.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ehs FUSION PROTEIN OF
CRFR1 EXTRACELLULAR
DOMAIN AND MBP

(Escherichia
coli;
Homo sapiens) 		PF02793
(HRM)
PF13416
(SBP_bac_8) 		9 ASP A-335
LYS A-334
LYS A-307
GLU A-305
ALA A-286
ASP A-284
ARG A-283
GLU A-238
TRP A-119
 MAL  A 126 (-2.9A)
MAL  A 126 (-2.7A)
None
None
MAL  A 126 (-3.1A)
MAL  A 126 (-2.8A)
MAL  A 126 (-4.0A)
MAL  A 126 (-2.6A)
MAL  A 126 ( 4.6A)
 0.71A 3jyrA-3ehsA:
61.2		 3jyrA-3ehsA:
72.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ehs FUSION PROTEIN OF
CRFR1 EXTRACELLULAR
DOMAIN AND MBP

(Escherichia
coli;
Homo sapiens) 		PF02793
(HRM)
PF13416
(SBP_bac_8) 		9 ASP A-335
LYS A-334
LYS A-307
GLU A-305
ALA A-286
ASP A-284
GLU A-238
PRO A-195
TRP A-119
 MAL  A 126 (-2.9A)
MAL  A 126 (-2.7A)
None
None
MAL  A 126 (-3.1A)
MAL  A 126 (-2.8A)
MAL  A 126 (-2.6A)
MAL  A 126 (-3.6A)
MAL  A 126 ( 4.6A)
 0.52A 3jyrA-3ehsA:
61.2		 3jyrA-3ehsA:
72.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3f5f MALTOSE-BINDING
PERIPLASMIC PROTEIN,
HEPARAN SULFATE
2-O-SULFOTRANSFERASE
1

(Escherichia
coli;
Gallus gallus) 		PF03567
(Sulfotransfer_2)
PF13416
(SBP_bac_8) 		9 ASP A  14
LYS A  15
LYS A  42
GLU A  44
GLU A  45
ALA A  63
ARG A  66
GLU A 111
TRP A 230
 GLC  A 672 (-3.2A)
GLC  A 672 (-2.9A)
None
GLC  A 671 ( 4.9A)
None
GLC  A 671 ( 3.4A)
GLC  A 671 (-3.9A)
GLC  A 672 (-2.7A)
GLC  A 672 (-4.3A)
 0.82A 3jyrA-3f5fA:
60.3		 3jyrA-3f5fA:
57.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3f5f MALTOSE-BINDING
PERIPLASMIC PROTEIN,
HEPARAN SULFATE
2-O-SULFOTRANSFERASE
1

(Escherichia
coli;
Gallus gallus) 		PF03567
(Sulfotransfer_2)
PF13416
(SBP_bac_8) 		10 ASP A  14
LYS A  15
LYS A  42
GLU A  44
GLU A  45
ALA A  63
ASP A  65
GLU A 111
PRO A 154
TRP A 230
 GLC  A 672 (-3.2A)
GLC  A 672 (-2.9A)
None
GLC  A 671 ( 4.9A)
None
GLC  A 671 ( 3.4A)
GLC  A 671 (-2.9A)
GLC  A 672 (-2.7A)
GLC  A 671 (-3.2A)
GLC  A 672 (-4.3A)
 0.49A 3jyrA-3f5fA:
60.3		 3jyrA-3f5fA:
57.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3h4z MALTOSE-BINDING
PERIPLASMIC PROTEIN
FUSED WITH ALLERGEN
DERP7

(Dermatophagoides
pteronyssinus;
Escherichia
coli) 		PF13416
(SBP_bac_8)
PF16984
(Grp7_allergen) 		9 ASP A  14
LYS A  15
GLU A  44
GLU A  45
ALA A  63
ASP A  65
GLU A 111
PRO A 154
TRP A 230
 GLC  A 672 (-3.1A)
GLC  A 672 (-2.7A)
None
None
GLC  A 671 ( 3.3A)
GLC  A 671 (-2.8A)
GLC  A 672 (-3.0A)
GLC  A 671 (-3.6A)
GLC  A 672 ( 4.6A)
 0.68A 3jyrA-3h4zA:
62.1		 3jyrA-3h4zA:
62.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3l2j FUSION PROTEIN OF
MALTOSE-BINDING
PERIPLASMIC PROTEIN
AND PARATHYROID
HORMONE/PARATHYROID
HORMONE-RELATED
PEPTIDE RECEPTOR

(Escherichia
coli;
Homo sapiens) 		PF02793
(HRM)
PF13416
(SBP_bac_8) 		9 ASP A-330
LYS A-329
LYS A-302
GLU A-300
ALA A-281
ASP A-279
ARG A-278
GLU A-233
TYR A  -3
 MAL  A 194 (-2.9A)
MAL  A 194 (-2.8A)
None
None
MAL  A 194 (-3.5A)
MAL  A 194 (-2.6A)
MAL  A 194 (-3.4A)
MAL  A 194 (-2.9A)
None
 0.91A 3jyrA-3l2jA:
53.8		 3jyrA-3l2jA:
67.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3l2j FUSION PROTEIN OF
MALTOSE-BINDING
PERIPLASMIC PROTEIN
AND PARATHYROID
HORMONE/PARATHYROID
HORMONE-RELATED
PEPTIDE RECEPTOR

(Escherichia
coli;
Homo sapiens) 		PF02793
(HRM)
PF13416
(SBP_bac_8) 		10 ASP A-330
LYS A-329
LYS A-302
GLU A-300
ALA A-281
ASP A-279
GLU A-233
PRO A-190
TRP A-114
TYR A  -3
 MAL  A 194 (-2.9A)
MAL  A 194 (-2.8A)
None
None
MAL  A 194 (-3.5A)
MAL  A 194 (-2.6A)
MAL  A 194 (-2.9A)
MAL  A 194 (-3.4A)
MAL  A 194 ( 4.6A)
None
 0.67A 3jyrA-3l2jA:
53.8		 3jyrA-3l2jA:
67.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mp6 MALTOSE-BINDING
PERIPLASMIC
PROTEIN,LINKER,SAGA-
ASSOCIATED FACTOR 29

(Escherichia
coli;
Saccharomyces
cerevisiae;
unidentified) 		PF07039
(DUF1325)
PF13416
(SBP_bac_8) 		10 ASP A 752
LYS A 753
LYS A 780
GLU A 782
GLU A 783
ALA A 801
ASP A 803
ARG A 804
GLU A 849
TYR A1079
 MAL  A 600 (-2.9A)
MAL  A 600 (-2.8A)
None
None
None
MAL  A 600 (-3.4A)
MAL  A 600 (-2.8A)
MAL  A 600 (-3.9A)
MAL  A 600 (-2.9A)
None
 0.91A 3jyrA-3mp6A:
62.3		 3jyrA-3mp6A:
63.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mp6 MALTOSE-BINDING
PERIPLASMIC
PROTEIN,LINKER,SAGA-
ASSOCIATED FACTOR 29

(Escherichia
coli;
Saccharomyces
cerevisiae;
unidentified) 		PF07039
(DUF1325)
PF13416
(SBP_bac_8) 		11 ASP A 752
LYS A 753
LYS A 780
GLU A 782
GLU A 783
ALA A 801
ASP A 803
GLU A 849
PRO A 892
TRP A 968
TYR A1079
 MAL  A 600 (-2.9A)
MAL  A 600 (-2.8A)
None
None
None
MAL  A 600 (-3.4A)
MAL  A 600 (-2.8A)
MAL  A 600 (-2.9A)
MAL  A 600 (-3.4A)
MAL  A 600 (-4.3A)
None
 0.60A 3jyrA-3mp6A:
62.3		 3jyrA-3mp6A:
63.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3n93 MALTOSE BINDING
PROTEIN-CRFR2 ALPHA

(Homo sapiens) 		PF02793
(HRM)
PF13416
(SBP_bac_8) 		9 ASP A-356
LYS A-355
LYS A-328
GLU A-326
GLU A-325
ALA A-307
ASP A-305
ARG A-304
GLU A-259
 MAL  A 111 (-3.1A)
MAL  A 111 (-2.7A)
None
None
None
MAL  A 111 (-3.3A)
MAL  A 111 (-2.8A)
MAL  A 111 (-3.6A)
MAL  A 111 (-3.4A)
 0.73A 3jyrA-3n93A:
61.9		 3jyrA-3n93A:
68.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3n93 MALTOSE BINDING
PROTEIN-CRFR2 ALPHA

(Homo sapiens) 		PF02793
(HRM)
PF13416
(SBP_bac_8) 		10 ASP A-356
LYS A-355
LYS A-328
GLU A-326
GLU A-325
ALA A-307
ASP A-305
GLU A-259
PRO A-216
TRP A-140
 MAL  A 111 (-3.1A)
MAL  A 111 (-2.7A)
None
None
None
MAL  A 111 (-3.3A)
MAL  A 111 (-2.8A)
MAL  A 111 (-3.4A)
MAL  A 111 (-3.5A)
MAL  A 111 ( 4.6A)
 0.44A 3jyrA-3n93A:
61.9		 3jyrA-3n93A:
68.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3n94 FUSION PROTEIN OF
MALTOSE-BINDING
PERIPLASMIC PROTEIN
AND PITUITARY
ADENYLATE CYCLASE 1
RECEPTOR-SHORT

(Escherichia
coli;
Homo sapiens) 		PF02793
(HRM)
PF13416
(SBP_bac_8) 		10 ASP A-334
LYS A-333
LYS A-306
GLU A-304
GLU A-303
ALA A-285
ASP A-283
ARG A-282
GLU A-237
TRP A-118
 MAL  A5044 (-3.1A)
MAL  A5044 (-2.7A)
None
None
None
MAL  A5044 (-3.3A)
MAL  A5044 (-2.8A)
MAL  A5044 (-3.8A)
MAL  A5044 (-2.9A)
MAL  A5044 ( 4.5A)
 0.77A 3jyrA-3n94A:
57.3		 3jyrA-3n94A:
79.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3n94 FUSION PROTEIN OF
MALTOSE-BINDING
PERIPLASMIC PROTEIN
AND PITUITARY
ADENYLATE CYCLASE 1
RECEPTOR-SHORT

(Escherichia
coli;
Homo sapiens) 		PF02793
(HRM)
PF13416
(SBP_bac_8) 		10 ASP A-334
LYS A-333
LYS A-306
GLU A-304
GLU A-303
ALA A-285
ASP A-283
GLU A-237
PRO A-194
TRP A-118
 MAL  A5044 (-3.1A)
MAL  A5044 (-2.7A)
None
None
None
MAL  A5044 (-3.3A)
MAL  A5044 (-2.8A)
MAL  A5044 (-2.9A)
MAL  A5044 (-3.3A)
MAL  A5044 ( 4.5A)
 0.50A 3jyrA-3n94A:
57.3		 3jyrA-3n94A:
79.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3o3u MALTOSE-BINDING
PERIPLASMIC PROTEIN,
ADVANCED
GLYCOSYLATION END
PRODUCT-SPECIFIC
RECEPTOR

(Escherichia
coli;
Homo sapiens) 		PF08205
(C2-set_2)
PF13416
(SBP_bac_8) 		12 ASP N  14
LYS N  15
LYS N  42
GLU N  44
GLU N  45
ALA N  63
ASP N  65
ARG N  66
GLU N 111
PRO N 154
TRP N 230
TYR N 341
 MLR  N2001 (-3.0A)
MLR  N2001 (-2.8A)
None
MLR  N2001 (-3.6A)
MLR  N2001 (-4.1A)
MLR  N2001 (-3.3A)
MLR  N2001 (-2.9A)
MLR  N2001 (-3.9A)
MLR  N2001 (-2.9A)
MLR  N2001 (-3.5A)
MLR  N2001 (-4.4A)
MLR  N2001 (-4.4A)
 0.24A 3jyrA-3o3uN:
63.3		 3jyrA-3o3uN:
71.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3oai MALTOSE-BINDING
PERIPLASMIC PROTEIN,
MYELIN PROTEIN P0

(Escherichia
coli;
Homo sapiens) 		PF07686
(V-set)
PF13416
(SBP_bac_8) 		9 ASP A  14
LYS A  15
GLU A  44
GLU A  45
ALA A  63
ASP A  65
ARG A  66
GLU A 111
TRP A 230
 MAL  A1122 (-3.3A)
MAL  A1122 (-2.7A)
MAL  A1122 ( 4.8A)
None
MAL  A1122 (-3.3A)
MAL  A1122 (-2.9A)
MAL  A1122 (-3.8A)
MAL  A1122 (-2.9A)
MAL  A1122 ( 4.7A)
 0.86A 3jyrA-3oaiA:
62.1		 3jyrA-3oaiA:
69.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3oai MALTOSE-BINDING
PERIPLASMIC PROTEIN,
MYELIN PROTEIN P0

(Escherichia
coli;
Homo sapiens) 		PF07686
(V-set)
PF13416
(SBP_bac_8) 		9 ASP A  14
LYS A  15
GLU A  44
GLU A  45
ALA A  63
ASP A  65
GLU A 111
PRO A 154
TRP A 230
 MAL  A1122 (-3.3A)
MAL  A1122 (-2.7A)
MAL  A1122 ( 4.8A)
None
MAL  A1122 (-3.3A)
MAL  A1122 (-2.9A)
MAL  A1122 (-2.9A)
MAL  A1122 (-3.5A)
MAL  A1122 ( 4.7A)
 0.66A 3jyrA-3oaiA:
62.1		 3jyrA-3oaiA:
69.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ob4 MALTOSE ABC
TRANSPORTER
PERIPLASMIC PROTEIN,
ARAH 2

(Arachis
duranensis;
Escherichia
coli) 		PF00234
(Tryp_alpha_amyl)
PF13416
(SBP_bac_8) 		12 ASP A  14
LYS A  15
LYS A  42
GLU A  44
GLU A  45
ALA A  63
ASP A  65
ARG A  66
GLU A 111
PRO A 154
TRP A 230
TYR A 341
 MLR  A 400 (-3.1A)
MLR  A 400 (-2.6A)
None
MLR  A 400 (-3.8A)
MLR  A 400 ( 4.6A)
MLR  A 400 (-2.9A)
MLR  A 400 (-2.7A)
MLR  A 400 (-3.8A)
MLR  A 400 (-2.7A)
MLR  A 400 (-3.7A)
MLR  A 400 (-4.3A)
MLR  A 400 (-4.7A)
 0.41A 3jyrA-3ob4A:
62.3		 3jyrA-3ob4A:
68.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3osq MALTOSE-BINDING
PERIPLASMIC
PROTEIN,GREEN
FLUORESCENT PROTEIN

(Aequorea
victoria;
Escherichia
coli) 		PF01353
(GFP)
PF01547
(SBP_bac_1)
PF13416
(SBP_bac_8) 		10 ASP A  14
LYS A  15
LYS A  42
GLU A  44
GLU A  45
ALA A  63
ASP A  65
ARG A  66
GLU A 111
TYR A 589
 MAL  A 700 (-2.8A)
MAL  A 700 (-2.8A)
None
None
None
MAL  A 700 (-3.3A)
MAL  A 700 (-2.8A)
MAL  A 700 (-3.6A)
MAL  A 700 (-2.9A)
None
 0.72A 3jyrA-3osqA:
45.3		 3jyrA-3osqA:
53.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3osq MALTOSE-BINDING
PERIPLASMIC
PROTEIN,GREEN
FLUORESCENT PROTEIN

(Aequorea
victoria;
Escherichia
coli) 		PF01353
(GFP)
PF01547
(SBP_bac_1)
PF13416
(SBP_bac_8) 		11 ASP A  14
LYS A  15
LYS A  42
GLU A  44
GLU A  45
ALA A  63
ASP A  65
GLU A 111
PRO A 154
TRP A 478
TYR A 589
 MAL  A 700 (-2.8A)
MAL  A 700 (-2.8A)
None
None
None
MAL  A 700 (-3.3A)
MAL  A 700 (-2.8A)
MAL  A 700 (-2.9A)
MAL  A 700 (-3.5A)
MAL  A 700 ( 4.6A)
None
 0.27A 3jyrA-3osqA:
45.3		 3jyrA-3osqA:
53.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3osr MALTOSE-BINDING
PERIPLASMIC
PROTEIN,GREEN
FLUORESCENT PROTEIN

(Aequorea
victoria;
Escherichia
coli) 		PF01353
(GFP)
PF01547
(SBP_bac_1) 		10 ASP A  14
LYS A  15
LYS A  42
GLU A  44
GLU A  45
ALA A  63
ASP A  65
GLU A 111
PRO A 154
TRP A 230
 MAL  A 700 (-3.1A)
MAL  A 700 (-2.8A)
None
None
None
MAL  A 700 (-3.3A)
MAL  A 700 (-2.8A)
MAL  A 700 (-3.0A)
MAL  A 700 (-3.6A)
MAL  A 700 ( 4.4A)
 0.37A 3jyrA-3osrA:
63.0		 3jyrA-3osrA:
53.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3py7 MALTOSE-BINDING
PERIPLASMIC
PROTEIN,PAXILLIN
LD1,PROTEIN E6
CHIMERA

(Deltapapillomavirus
4;
Escherichia
coli;
Homo sapiens) 		PF00518
(E6)
PF01547
(SBP_bac_1) 		12 ASP A  15
LYS A  16
LYS A  43
GLU A  45
GLU A  46
ALA A  64
ASP A  66
ARG A  67
GLU A 112
PRO A 155
TRP A 231
TYR A 342
 MLR  A 701 (-3.0A)
MLR  A 701 (-2.7A)
None
MLR  A 701 (-3.6A)
MLR  A 701 (-4.2A)
MLR  A 701 (-3.3A)
MLR  A 701 (-2.8A)
MLR  A 701 (-3.8A)
MLR  A 701 (-3.0A)
MLR  A 701 (-3.6A)
MLR  A 701 ( 4.5A)
MLR  A 701 (-4.3A)
 0.37A 3jyrA-3py7A:
62.9		 3jyrA-3py7A:
68.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3vd8 MALTOSE-BINDING
PERIPLASMIC PROTEIN,
INTERFERON-INDUCIBLE
PROTEIN AIM2

(Escherichia
coli;
Homo sapiens) 		PF02758
(PYRIN)
PF13416
(SBP_bac_8) 		12 ASP A  14
LYS A  15
LYS A  42
GLU A  44
GLU A  45
ALA A  63
ASP A  65
ARG A  66
GLU A 111
PRO A 154
TRP A 230
TYR A 341
 MTT  A1205 (-3.1A)
MTT  A1205 (-2.8A)
MTT  A1205 (-2.7A)
MTT  A1205 (-2.9A)
MTT  A1205 (-3.5A)
MTT  A1205 (-3.3A)
MTT  A1205 ( 2.8A)
MTT  A1205 ( 3.8A)
MTT  A1205 (-2.9A)
MTT  A1205 (-3.5A)
MTT  A1205 (-4.3A)
MTT  A1205 (-4.5A)
 0.40A 3jyrA-3vd8A:
62.6		 3jyrA-3vd8A:
69.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4edq MALTOSE-BINDING
PERIPLASMIC
PROTEIN,MYOSIN-BINDI
NG PROTEIN C,
CARDIAC-TYPE
CHIMERIC PROTEIN

(Escherichia
coli;
Mus musculus) 		PF07679
(I-set)
PF13416
(SBP_bac_8) 		12 ASP A  15
LYS A  16
LYS A  43
GLU A  45
GLU A  46
ALA A  64
ASP A  66
ARG A  67
GLU A 112
PRO A 155
TRP A 231
TYR A 342
 MLR  A 500 (-1.9A)
MLR  A 500 (-2.7A)
None
MLR  A 500 (-2.6A)
MLR  A 500 (-3.4A)
MLR  A 500 (-2.8A)
MLR  A 500 (-2.1A)
MLR  A 500 (-3.6A)
MLR  A 500 (-2.2A)
MLR  A 500 (-3.0A)
MLR  A 500 (-4.2A)
MLR  A 500 (-3.7A)
 0.23A 3jyrA-4edqA:
60.8		 3jyrA-4edqA:
71.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4egc MALTOSE-BINDING
PERIPLASMIC PROTEIN,
HOMEOBOX PROTEIN
SIX1 CHIMERA

(Escherichia
coli;
Homo sapiens) 		PF00046
(Homeobox)
PF13416
(SBP_bac_8)
PF16878
(SIX1_SD) 		9 ASP A  14
LYS A  15
GLU A  44
GLU A  45
ALA A  63
ASP A  65
ARG A  66
GLU A 111
TRP A 230
 MAL  A 601 (-2.9A)
MAL  A 601 (-2.7A)
None
None
MAL  A 601 (-3.2A)
MAL  A 601 (-2.9A)
MAL  A 601 (-3.8A)
MAL  A 601 (-2.9A)
MAL  A 601 (-4.5A)
 0.78A 3jyrA-4egcA:
55.6		 3jyrA-4egcA:
63.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4egc MALTOSE-BINDING
PERIPLASMIC PROTEIN,
HOMEOBOX PROTEIN
SIX1 CHIMERA

(Escherichia
coli;
Homo sapiens) 		PF00046
(Homeobox)
PF13416
(SBP_bac_8)
PF16878
(SIX1_SD) 		9 ASP A  14
LYS A  15
GLU A  44
GLU A  45
ALA A  63
ASP A  65
GLU A 111
PRO A 154
TRP A 230
 MAL  A 601 (-2.9A)
MAL  A 601 (-2.7A)
None
None
MAL  A 601 (-3.2A)
MAL  A 601 (-2.9A)
MAL  A 601 (-2.9A)
MAL  A 601 (-3.5A)
MAL  A 601 (-4.5A)
 0.55A 3jyrA-4egcA:
55.6		 3jyrA-4egcA:
63.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4exk MALTOSE-BINDING
PERIPLASMIC PROTEIN,
UNCHARACTERIZED
PROTEIN CHIMERA

(Escherichia
coli;
Salmonella
enterica) 		PF13416
(SBP_bac_8)
PF16583
(ZirS_C) 		12 ASP A  14
LYS A  15
LYS A  42
GLU A  44
GLU A  45
ALA A  63
ASP A  65
ARG A  66
GLU A 111
PRO A 154
TRP A 230
TYR A 341
 MTT  A 501 (-2.9A)
MTT  A 501 (-2.8A)
MTT  A 501 (-4.1A)
MTT  A 501 (-3.1A)
MTT  A 501 (-3.6A)
MTT  A 501 (-3.3A)
MTT  A 501 (-2.8A)
MTT  A 501 (-3.8A)
MTT  A 501 (-2.8A)
MTT  A 501 (-3.4A)
MTT  A 501 (-4.3A)
MTT  A 501 (-4.6A)
 0.23A 3jyrA-4exkA:
62.4		 3jyrA-4exkA:
72.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4h1g MALTOSE BINDING
PROTEIN-CAKAR3 MOTOR
DOMAIN FUSION
PROTEIN

(Candida
albicans;
Escherichia
coli) 		PF00225
(Kinesin)
PF13416
(SBP_bac_8) 		11 ASP A-356
LYS A-355
GLU A-326
GLU A-325
ALA A-307
ASP A-305
ARG A-304
GLU A-259
PRO A-216
TRP A-140
TYR A -29
 MTT  A 701 (-2.9A)
MTT  A 701 (-2.8A)
MTT  A 701 (-3.1A)
MTT  A 701 (-3.4A)
MTT  A 701 (-3.2A)
MTT  A 701 (-2.7A)
MTT  A 701 (-3.8A)
MTT  A 701 (-3.0A)
MTT  A 701 (-3.5A)
MTT  A 701 (-4.3A)
MTT  A 701 (-4.6A)
 0.18A 3jyrA-4h1gA:
63.0		 3jyrA-4h1gA:
47.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ifp MALTOSE-BINDING
PERIPLASMIC
PROTEIN,NACHT, LRR
AND PYD
DOMAINS-CONTAINING
PROTEIN 1

(Escherichia
coli;
Homo sapiens) 		PF00619
(CARD)
PF13416
(SBP_bac_8) 		9 ASP A  15
LYS A  16
LYS A  43
GLU A  45
GLU A  46
ALA A  64
ASP A  66
ARG A  67
GLU A 112
 MAL  A 501 (-3.0A)
MAL  A 501 (-2.6A)
None
None
None
MAL  A 501 (-3.3A)
MAL  A 501 (-2.9A)
MAL  A 501 (-3.8A)
MAL  A 501 (-3.0A)
 0.73A 3jyrA-4ifpA:
61.5		 3jyrA-4ifpA:
81.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ifp MALTOSE-BINDING
PERIPLASMIC
PROTEIN,NACHT, LRR
AND PYD
DOMAINS-CONTAINING
PROTEIN 1

(Escherichia
coli;
Homo sapiens) 		PF00619
(CARD)
PF13416
(SBP_bac_8) 		10 ASP A  15
LYS A  16
LYS A  43
GLU A  45
GLU A  46
ALA A  64
ASP A  66
GLU A 112
PRO A 155
TRP A 231
 MAL  A 501 (-3.0A)
MAL  A 501 (-2.6A)
None
None
None
MAL  A 501 (-3.3A)
MAL  A 501 (-2.9A)
MAL  A 501 (-3.0A)
MAL  A 501 (-3.4A)
MAL  A 501 (-4.4A)
 0.41A 3jyrA-4ifpA:
61.5		 3jyrA-4ifpA:
81.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ikm MALTOSE-BINDING
PERIPLASMIC PROTEIN,
CASPASE RECRUITMENT
DOMAIN-CONTAINING
PROTEIN 8

(Escherichia
coli;
Homo sapiens) 		PF00619
(CARD)
PF13416
(SBP_bac_8) 		10 ASP A  15
LYS A  16
LYS A  43
GLU A  45
GLU A  46
ALA A  64
ASP A  66
ARG A  67
GLU A 112
TRP A 231
 MAL  A 501 (-3.1A)
MAL  A 501 (-3.1A)
None
None
None
MAL  A 501 (-3.2A)
MAL  A 501 (-2.9A)
MAL  A 501 (-3.9A)
MAL  A 501 (-2.9A)
MAL  A 501 ( 4.6A)
 0.79A 3jyrA-4ikmA:
61.7		 3jyrA-4ikmA:
77.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ikm MALTOSE-BINDING
PERIPLASMIC PROTEIN,
CASPASE RECRUITMENT
DOMAIN-CONTAINING
PROTEIN 8

(Escherichia
coli;
Homo sapiens) 		PF00619
(CARD)
PF13416
(SBP_bac_8) 		10 ASP A  15
LYS A  16
LYS A  43
GLU A  45
GLU A  46
ALA A  64
ASP A  66
GLU A 112
PRO A 155
TRP A 231
 MAL  A 501 (-3.1A)
MAL  A 501 (-3.1A)
None
None
None
MAL  A 501 (-3.2A)
MAL  A 501 (-2.9A)
MAL  A 501 (-2.9A)
MAL  A 501 (-3.3A)
MAL  A 501 ( 4.6A)
 0.53A 3jyrA-4ikmA:
61.7		 3jyrA-4ikmA:
77.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4irl MALTOSE-BINDING
PERIPLASMIC PROTEIN,
NOVEL PROTEIN
SIMILAR TO
VERTEBRATE GUANYLATE
BINDING PROTEIN
FAMILY

(Danio rerio;
Escherichia
coli) 		PF00619
(CARD)
PF13416
(SBP_bac_8) 		12 ASP A  15
LYS A  16
LYS A  43
GLU A  45
GLU A  46
ALA A  64
ASP A  66
ARG A  67
GLU A 112
PRO A 155
TRP A 231
TYR A 342
 MTT  A 501 (-3.0A)
MTT  A 501 (-2.8A)
MTT  A 501 (-3.8A)
MTT  A 501 (-2.9A)
MTT  A 501 (-3.5A)
MTT  A 501 (-3.4A)
MTT  A 501 (-2.8A)
MTT  A 501 (-3.8A)
MTT  A 501 (-2.9A)
MTT  A 501 (-3.6A)
MTT  A 501 (-4.4A)
MTT  A 501 (-4.4A)
 0.20A 3jyrA-4irlA:
62.9		 3jyrA-4irlA:
77.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4kv3 CHIMERA FUSION
PROTEIN OF ESX-1
SECRETION SYSTEM
PROTEIN ECCD1 AND
MALTOSE-BINDING
PERIPLASMIC PROTEIN

(Escherichia
coli;
Mycobacterium
tuberculosis) 		PF08817
(YukD)
PF13416
(SBP_bac_8) 		11 ASP A  15
LYS A  16
LYS A  43
GLU A  45
GLU A  46
ALA A  64
ASP A  66
ARG A  67
GLU A 112
TRP A 231
TYR A 342
 MAL  A 501 (-2.9A)
MAL  A 501 (-2.6A)
None
None
None
MAL  A 501 (-3.2A)
MAL  A 501 (-2.7A)
MAL  A 501 (-4.0A)
MAL  A 501 (-3.0A)
MAL  A 501 ( 4.7A)
None
 0.66A 3jyrA-4kv3A:
61.6		 3jyrA-4kv3A:
74.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4kv3 CHIMERA FUSION
PROTEIN OF ESX-1
SECRETION SYSTEM
PROTEIN ECCD1 AND
MALTOSE-BINDING
PERIPLASMIC PROTEIN

(Escherichia
coli;
Mycobacterium
tuberculosis) 		PF08817
(YukD)
PF13416
(SBP_bac_8) 		11 ASP A  15
LYS A  16
LYS A  43
GLU A  45
GLU A  46
ALA A  64
ASP A  66
GLU A 112
PRO A 155
TRP A 231
TYR A 342
 MAL  A 501 (-2.9A)
MAL  A 501 (-2.6A)
None
None
None
MAL  A 501 (-3.2A)
MAL  A 501 (-2.7A)
MAL  A 501 (-3.0A)
MAL  A 501 (-3.6A)
MAL  A 501 ( 4.7A)
None
 0.47A 3jyrA-4kv3A:
61.6		 3jyrA-4kv3A:
74.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4my2 MALTOSE-BINDING
PERIPLASMIC PROTEIN,
NORRIN FUSION
PROTEIN

(Escherichia
coli;
Homo sapiens) 		PF00007
(Cys_knot)
PF13416
(SBP_bac_8) 		9 ASP A  16
LYS A  17
LYS A  44
GLU A  46
GLU A  47
ALA A  65
ARG A  68
GLU A 113
TRP A 232
 MAL  A1201 (-3.0A)
MAL  A1201 (-2.5A)
None
None
None
MAL  A1201 (-3.2A)
MAL  A1201 (-3.9A)
MAL  A1201 (-3.1A)
MAL  A1201 ( 4.6A)
 0.77A 3jyrA-4my2A:
62.0		 3jyrA-4my2A:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4my2 MALTOSE-BINDING
PERIPLASMIC PROTEIN,
NORRIN FUSION
PROTEIN

(Escherichia
coli;
Homo sapiens) 		PF00007
(Cys_knot)
PF13416
(SBP_bac_8) 		10 ASP A  16
LYS A  17
LYS A  44
GLU A  46
GLU A  47
ALA A  65
ASP A  67
GLU A 113
PRO A 156
TRP A 232
 MAL  A1201 (-3.0A)
MAL  A1201 (-2.5A)
None
None
None
MAL  A1201 (-3.2A)
MAL  A1201 (-2.8A)
MAL  A1201 (-3.1A)
MAL  A1201 (-3.7A)
MAL  A1201 ( 4.6A)
 0.51A 3jyrA-4my2A:
62.0		 3jyrA-4my2A:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4nuf MALTOSE ABC
TRANSPORTER
PERIPLASMIC PROTEIN,
NUCLEAR RECEPTOR
SUBFAMILY 0 GROUP B
MEMBER 2 CHIMERIC
CONSTRUCT

(Escherichia
coli;
Mus musculus) 		PF00104
(Hormone_recep)
PF13416
(SBP_bac_8) 		9 ASP A  16
LYS A  17
GLU A  46
GLU A  47
ALA A  65
ASP A  67
ARG A  68
GLU A 113
TRP A 232
 MAL  A1301 (-3.1A)
MAL  A1301 (-3.1A)
MAL  A1301 ( 3.9A)
None
MAL  A1301 (-3.3A)
MAL  A1301 (-2.9A)
MAL  A1301 (-3.8A)
MAL  A1301 (-2.8A)
MAL  A1301 (-4.6A)
 0.96A 3jyrA-4nufA:
55.4		 3jyrA-4nufA:
58.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4pe2 MALTOSE ABC
TRANSPORTER
PERIPLASMIC
PROTEIN,PREPILIN-TYP
E N-TERMINAL
CLEAVAGE/METHYLATION
DOMAIN PROTEIN

(Clostridioides
difficile;
Escherichia
coli) 		PF13416
(SBP_bac_8) 		10 ASP A  14
LYS A  15
LYS A  42
GLU A  44
GLU A  45
ALA A  63
ASP A  65
ARG A  66
GLU A 111
TRP A 230
 MAL  A 601 (-3.1A)
MAL  A 601 (-2.8A)
None
None
None
MAL  A 601 (-3.3A)
MAL  A 601 (-2.9A)
MAL  A 601 (-3.8A)
MAL  A 601 (-3.1A)
MAL  A 601 (-4.5A)
 0.72A 3jyrA-4pe2A:
54.3		 3jyrA-4pe2A:
72.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4pe2 MALTOSE ABC
TRANSPORTER
PERIPLASMIC
PROTEIN,PREPILIN-TYP
E N-TERMINAL
CLEAVAGE/METHYLATION
DOMAIN PROTEIN

(Clostridioides
difficile;
Escherichia
coli) 		PF13416
(SBP_bac_8) 		10 ASP A  14
LYS A  15
LYS A  42
GLU A  44
GLU A  45
ALA A  63
ASP A  65
GLU A 111
PRO A 154
TRP A 230
 MAL  A 601 (-3.1A)
MAL  A 601 (-2.8A)
None
None
None
MAL  A 601 (-3.3A)
MAL  A 601 (-2.9A)
MAL  A 601 (-3.1A)
MAL  A 601 (-3.5A)
MAL  A 601 (-4.5A)
 0.44A 3jyrA-4pe2A:
54.3		 3jyrA-4pe2A:
72.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4pqk MALTOSE ABC
TRANSPORTER
PERIPLASMIC PROTEIN,
TRUNCATED
REPLICATION PROTEIN
REPA

(Escherichia
coli;
Staphylococcus
aureus) 		PF13416
(SBP_bac_8) 		12 ASP A  15
LYS A  16
LYS A  43
GLU A  45
GLU A  46
ALA A  64
ASP A  66
ARG A  67
GLU A 112
PRO A 155
TRP A 231
TYR A 342
 MLR  A 700 (-3.0A)
MLR  A 700 (-2.5A)
None
MLR  A 700 (-3.2A)
MLR  A 700 (-4.1A)
MLR  A 700 (-3.2A)
MLR  A 700 (-2.7A)
MLR  A 700 (-2.9A)
MLR  A 700 (-3.0A)
MLR  A 700 (-3.6A)
MLR  A 700 (-4.4A)
MLR  A 700 (-3.9A)
 0.45A 3jyrA-4pqkA:
54.4		 3jyrA-4pqkA:
76.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4qsz MALTOSE-BINDING
PERIPLASMIC PROTEIN,
JMJC
DOMAIN-CONTAINING
PROTEIN 7 CHIMERA

(Escherichia
coli;
Mus musculus) 		PF13416
(SBP_bac_8)
PF13621
(Cupin_8) 		12 ASP A-357
LYS A-356
LYS A-329
GLU A-327
GLU A-326
ALA A-308
ASP A-306
ARG A-305
GLU A-260
PRO A-217
TRP A-141
TYR A -30
 GLC  A 901 (-2.9A)
GLC  A 901 (-3.0A)
None
FLC  A 903 (-3.9A)
FLC  A 903 (-3.5A)
GLC  A 902 (-3.1A)
GLC  A 902 (-2.9A)
FLC  A 903 (-3.9A)
GLC  A 901 (-3.1A)
GLC  A 902 ( 3.7A)
GLC  A 901 (-4.0A)
FLC  A 903 (-3.9A)
 0.39A 3jyrA-4qszA:
60.3		 3jyrA-4qszA:
50.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4rwf MALTOSE TRANSPORTER
SUBUNIT, RECEPTOR
ACTIVITY-MODIFYING
PROTEIN 2,
CALCITONIN
GENE-RELATED PEPTIDE
TYPE 1 RECEPTOR
FUSION PROTEIN

(Escherichia
coli;
Homo sapiens) 		PF02793
(HRM)
PF04901
(RAMP)
PF13416
(SBP_bac_8) 		10 ASP A  16
LYS A  17
LYS A  44
GLU A  46
GLU A  47
ALA A  65
ASP A  67
ARG A  68
GLU A 113
TRP A 232
 MAL  A2201 (-3.0A)
MAL  A2201 ( 2.7A)
None
None
None
MAL  A2201 (-3.4A)
MAL  A2201 (-2.8A)
MAL  A2201 (-3.8A)
MAL  A2201 (-3.0A)
MAL  A2201 ( 4.5A)
 0.64A 3jyrA-4rwfA:
61.9		 3jyrA-4rwfA:
61.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4rwf MALTOSE TRANSPORTER
SUBUNIT, RECEPTOR
ACTIVITY-MODIFYING
PROTEIN 2,
CALCITONIN
GENE-RELATED PEPTIDE
TYPE 1 RECEPTOR
FUSION PROTEIN

(Escherichia
coli;
Homo sapiens) 		PF02793
(HRM)
PF04901
(RAMP)
PF13416
(SBP_bac_8) 		10 ASP A  16
LYS A  17
LYS A  44
GLU A  46
GLU A  47
ALA A  65
ASP A  67
GLU A 113
PRO A 156
TRP A 232
 MAL  A2201 (-3.0A)
MAL  A2201 ( 2.7A)
None
None
None
MAL  A2201 (-3.4A)
MAL  A2201 (-2.8A)
MAL  A2201 (-3.0A)
MAL  A2201 (-3.4A)
MAL  A2201 ( 4.5A)
 0.31A 3jyrA-4rwfA:
61.9		 3jyrA-4rwfA:
61.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4tsm MALTOSE-BINDING
PROTEIN, PILIN
CHIMERA

(Clostridioides
difficile;
Escherichia
coli) 		PF13416
(SBP_bac_8) 		12 ASP A  14
LYS A  15
LYS A  42
GLU A  44
GLU A  45
ALA A  63
ASP A  65
ARG A  66
GLU A 111
PRO A 154
TRP A 230
TYR A 341
 MTT  A1209 (-3.0A)
MTT  A1209 (-2.9A)
MTT  A1209 (-3.3A)
MTT  A1209 (-3.1A)
MTT  A1209 (-3.6A)
MTT  A1209 (-3.2A)
MTT  A1209 (-2.7A)
MTT  A1209 (-3.9A)
MTT  A1209 (-2.9A)
MTT  A1209 (-3.5A)
MTT  A1209 (-4.3A)
MTT  A1209 (-4.5A)
 0.18A 3jyrA-4tsmA:
60.8		 3jyrA-4tsmA:
66.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4wrn MALTOSE-BINDING
PERIPLASMIC
PROTEIN,UROMODULIN

(Escherichia
coli;
Homo sapiens) 		PF00100
(Zona_pellucida)
PF13416
(SBP_bac_8) 		11 ASP A  38
LYS A  39
GLU A  68
GLU A  69
ALA A  87
ASP A  89
ARG A  90
GLU A 135
PRO A 178
TRP A 254
TYR A 365
 MAL  A 801 (-3.0A)
MAL  A 801 (-3.0A)
None
None
MAL  A 801 (-2.8A)
MAL  A 801 (-2.8A)
None
MAL  A 801 (-2.8A)
MAL  A 801 (-3.2A)
MAL  A 801 ( 3.6A)
None
 0.73A 3jyrA-4wrnA:
59.5		 3jyrA-4wrnA:
48.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4wrn MALTOSE-BINDING
PERIPLASMIC
PROTEIN,UROMODULIN

(Escherichia
coli;
Homo sapiens) 		PF00100
(Zona_pellucida)
PF13416
(SBP_bac_8) 		11 ASP A  38
LYS A  39
LYS A  66
GLU A  68
GLU A  69
ALA A  87
ASP A  89
ARG A  90
GLU A 135
PRO A 178
TRP A 254
 MAL  A 801 (-3.0A)
MAL  A 801 (-3.0A)
None
None
None
MAL  A 801 (-2.8A)
MAL  A 801 (-2.8A)
None
MAL  A 801 (-2.8A)
MAL  A 801 (-3.2A)
MAL  A 801 ( 3.6A)
 0.56A 3jyrA-4wrnA:
59.5		 3jyrA-4wrnA:
48.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4wvi MALTOSE-BINDING
PERIPLASMIC
PROTEIN,SIGNAL
PEPTIDASE IB

(Escherichia
coli;
Staphylococcus
aureus) 		PF00717
(Peptidase_S24)
PF13416
(SBP_bac_8) 		9 ASP A  20
LYS A  21
GLU A  50
GLU A  51
ALA A  69
ASP A  71
GLU A 117
PRO A 160
TRP A 236
 MAL  A 601 (-3.0A)
MAL  A 601 (-2.6A)
None
None
MAL  A 601 (-3.3A)
MAL  A 601 (-2.8A)
MAL  A 601 (-2.9A)
MAL  A 601 (-3.5A)
MAL  A 601 ( 4.6A)
 0.29A 3jyrA-4wviA:
61.6		 3jyrA-4wviA:
61.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xa2 MALTOSE-BINDING
PERIPLASMIC
PROTEIN,MBP-PILA: C

(Acinetobacter
baumannii;
Escherichia
coli) 		PF00114
(Pilin)
PF13416
(SBP_bac_8) 		11 ASP A  14
LYS A  15
GLU A  44
GLU A  45
ALA A  63
ASP A  65
ARG A  66
GLU A 111
PRO A 154
TRP A 230
TYR A 341
 MLR  A1201 (-3.2A)
MLR  A1201 (-2.9A)
MLR  A1201 (-3.5A)
MLR  A1201 (-3.8A)
MLR  A1201 (-3.3A)
MLR  A1201 (-2.9A)
MLR  A1201 (-4.0A)
MLR  A1201 (-3.1A)
MLR  A1201 (-3.5A)
MLR  A1201 (-4.4A)
MLR  A1201 (-4.1A)
 0.34A 3jyrA-4xa2A:
62.4		 3jyrA-4xa2A:
73.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xai MALTOSE-BINDING
PERIPLASMIC
PROTEIN,TAILLESS
ORTHOLOG

(Escherichia
coli;
Tribolium
castaneum) 		PF00104
(Hormone_recep)
PF13416
(SBP_bac_8) 		9 ASP A  16
LYS A  17
LYS A  44
GLU A  46
GLU A  47
ALA A  65
ASP A  67
ARG A  68
TRP A 232
 MAL  A1401 (-3.2A)
MAL  A1401 (-2.6A)
None
None
None
MAL  A1401 (-3.4A)
MAL  A1401 (-2.7A)
MAL  A1401 (-4.3A)
MAL  A1401 (-4.3A)
 0.75A 3jyrA-4xaiA:
62.1		 3jyrA-4xaiA:
77.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xai MALTOSE-BINDING
PERIPLASMIC
PROTEIN,TAILLESS
ORTHOLOG

(Escherichia
coli;
Tribolium
castaneum) 		PF00104
(Hormone_recep)
PF13416
(SBP_bac_8) 		10 ASP A  16
LYS A  17
LYS A  44
GLU A  46
GLU A  47
ALA A  65
ASP A  67
GLU A 113
PRO A 156
TRP A 232
 MAL  A1401 (-3.2A)
MAL  A1401 (-2.6A)
None
None
None
MAL  A1401 (-3.4A)
MAL  A1401 (-2.7A)
MAL  A1401 (-3.0A)
MAL  A1401 (-3.8A)
MAL  A1401 (-4.3A)
 0.50A 3jyrA-4xaiA:
62.1		 3jyrA-4xaiA:
77.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xaj MALTOSE-BINDING
PERIPLASMIC
PROTEIN,NUCLEAR
RECEPTOR SUBFAMILY 2
GROUP E MEMBER 1

(Escherichia
coli;
Homo sapiens) 		PF00104
(Hormone_recep)
PF13416
(SBP_bac_8) 		10 ASP A  16
LYS A  17
LYS A  44
GLU A  46
GLU A  47
ALA A  65
ASP A  67
ARG A  68
GLU A 113
TRP A 232
 MAL  A1900 (-3.2A)
MAL  A1900 (-2.2A)
None
MAL  A1900 (-3.4A)
None
MAL  A1900 (-3.3A)
MAL  A1900 (-2.8A)
MAL  A1900 (-4.1A)
MAL  A1900 (-2.8A)
MAL  A1900 ( 4.9A)
 0.94A 3jyrA-4xajA:
61.9		 3jyrA-4xajA:
58.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xaj MALTOSE-BINDING
PERIPLASMIC
PROTEIN,NUCLEAR
RECEPTOR SUBFAMILY 2
GROUP E MEMBER 1

(Escherichia
coli;
Homo sapiens) 		PF00104
(Hormone_recep)
PF13416
(SBP_bac_8) 		9 ASP A  16
LYS A  17
LYS A  44
GLU A  47
ALA A  65
ASP A  67
GLU A 113
PRO A 156
TRP A 232
 MAL  A1900 (-3.2A)
MAL  A1900 (-2.2A)
None
None
MAL  A1900 (-3.3A)
MAL  A1900 (-2.8A)
MAL  A1900 (-2.8A)
MAL  A1900 (-3.4A)
MAL  A1900 ( 4.9A)
 0.47A 3jyrA-4xajA:
61.9		 3jyrA-4xajA:
58.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5aza MALTOSE-BINDING
PERIPLASMIC
PROTEIN,OLIGOSACCHAR
YL TRANSFERASE STT3
SUBUNIT RELATED
PROTEIN

(Escherichia
coli;
Pyrococcus
furiosus) 		PF13416
(SBP_bac_8) 		10 ASP A  14
LYS A  15
LYS A  42
GLU A  44
GLU A  45
ALA A  63
ASP A  65
ARG A  66
GLU A 111
TRP A 230
 MAL  A 901 (-2.9A)
MAL  A 901 (-2.8A)
None
None
None
MAL  A 901 (-3.3A)
MAL  A 901 (-2.9A)
MAL  A 901 (-3.9A)
MAL  A 901 (-3.1A)
MAL  A 901 ( 4.6A)
 0.72A 3jyrA-5azaA:
58.0		 3jyrA-5azaA:
42.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5aza MALTOSE-BINDING
PERIPLASMIC
PROTEIN,OLIGOSACCHAR
YL TRANSFERASE STT3
SUBUNIT RELATED
PROTEIN

(Escherichia
coli;
Pyrococcus
furiosus) 		PF13416
(SBP_bac_8) 		10 ASP A  14
LYS A  15
LYS A  42
GLU A  44
GLU A  45
ALA A  63
ASP A  65
GLU A 111
PRO A 154
TRP A 230
 MAL  A 901 (-2.9A)
MAL  A 901 (-2.8A)
None
None
None
MAL  A 901 (-3.3A)
MAL  A 901 (-2.9A)
MAL  A 901 (-3.1A)
MAL  A 901 (-3.5A)
MAL  A 901 ( 4.6A)
 0.46A 3jyrA-5azaA:
58.0		 3jyrA-5azaA:
42.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5c7r FUSION PROTEIN OF
MALTOSE-BINDING
PERIPLASMIC PROTEIN
AND TYPE-3
ICE-STRUCTURING
PROTEIN HPLC 12

(Escherichia
coli;
Zoarces
americanus) 		PF01547
(SBP_bac_1) 		12 ASP A  14
LYS A  15
LYS A  42
GLU A  44
GLU A  45
ALA A  63
ASP A  65
ARG A  66
GLU A 111
PRO A 154
TRP A 230
TYR A 341
 MLR  A 501 (-2.9A)
MLR  A 501 (-2.6A)
None
MLR  A 501 (-3.8A)
MLR  A 501 (-4.2A)
MLR  A 501 (-3.2A)
MLR  A 501 (-2.8A)
MLR  A 501 (-3.5A)
MLR  A 501 (-2.9A)
MLR  A 501 (-3.4A)
MLR  A 501 ( 4.5A)
MLR  A 501 ( 4.3A)
 0.37A 3jyrA-5c7rA:
62.7		 3jyrA-5c7rA:
76.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5cfv MALTOSE-BINDING
PERIPLASMIC
PROTEIN,MALTOSE-BIND
ING PERIPLASMIC
PROTEIN,PILA FUSION
PROTEIN

(Acinetobacter
nosocomialis;
Escherichia
coli) 		PF00114
(Pilin)
PF01547
(SBP_bac_1) 		9 ASP A  14
LYS A  15
LYS A  42
GLU A  44
GLU A  45
ALA A  63
ASP A  65
ARG A  66
GLU A 111
 MAL  A1201 (-3.0A)
MAL  A1201 (-2.8A)
None
None
None
MAL  A1201 (-3.3A)
MAL  A1201 (-2.8A)
MAL  A1201 (-3.8A)
MAL  A1201 (-3.0A)
 0.79A 3jyrA-5cfvA:
55.2		 3jyrA-5cfvA:
72.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5cfv MALTOSE-BINDING
PERIPLASMIC
PROTEIN,MALTOSE-BIND
ING PERIPLASMIC
PROTEIN,PILA FUSION
PROTEIN

(Acinetobacter
nosocomialis;
Escherichia
coli) 		PF00114
(Pilin)
PF01547
(SBP_bac_1) 		10 ASP A  14
LYS A  15
LYS A  42
GLU A  44
GLU A  45
ALA A  63
ASP A  65
GLU A 111
PRO A 154
TRP A 230
 MAL  A1201 (-3.0A)
MAL  A1201 (-2.8A)
None
None
None
MAL  A1201 (-3.3A)
MAL  A1201 (-2.8A)
MAL  A1201 (-3.0A)
MAL  A1201 (-3.4A)
MAL  A1201 ( 4.5A)
 0.50A 3jyrA-5cfvA:
55.2		 3jyrA-5cfvA:
72.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5edu MALTOSE-BINDING
PERIPLASMIC PROTEIN,
HISTONE DEACETYLASE
6 CHIMERA

(Escherichia
coli;
Homo sapiens) 		no annotation 10 ASP B 122
LYS B 123
LYS B 150
GLU B 152
GLU B 153
ALA B 171
ASP B 173
GLU B 219
PRO B 262
TRP B 338
 MAL  B2505 (-3.2A)
MAL  B2505 (-2.9A)
None
None
None
MAL  B2505 (-3.3A)
MAL  B2505 (-2.7A)
MAL  B2505 (-3.2A)
MAL  B2505 (-3.7A)
MAL  B2505 ( 4.6A)
 0.57A 3jyrA-5eduB:
60.0		 3jyrA-5eduB:
47.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5fsg MALTOSE-BINDING
PERIPLASMIC PROTEIN,
HANTAVIRUS
NUCLEOPROTEIN

(Hantaan
orthohantavirus) 		PF00846
(Hanta_nucleocap)
PF13416
(SBP_bac_8) 		10 ASP A-358
LYS A-357
GLU A-328
GLU A-327
ALA A-309
ARG A-306
GLU A-261
PRO A-218
TRP A-142
TYR A -31
 MTT  A1431 (-2.5A)
MTT  A1431 (-2.7A)
MTT  A1431 (-2.8A)
MTT  A1431 (-3.0A)
MTT  A1431 (-3.2A)
MTT  A1431 (-3.5A)
MTT  A1431 (-2.5A)
MTT  A1431 (-2.8A)
MTT  A1431 (-3.5A)
MTT  A1431 (-3.8A)
 0.57A 3jyrA-5fsgA:
58.1		 3jyrA-5fsgA:
62.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5gpp MALTOSE-BINDING
PERIPLASMIC
PROTEIN,APOPTOSIS-AS
SOCIATED SPECK-LIKE
PROTEIN CONTAINING A
CARD

(Danio rerio;
Escherichia
coli) 		PF02758
(PYRIN)
PF13416
(SBP_bac_8) 		9 ASP A  15
LYS A  16
GLU A  45
GLU A  46
ALA A  64
ASP A  66
ARG A  67
GLU A 112
TRP A 231
 MAL  A 501 (-3.4A)
MAL  A 501 (-3.1A)
None
None
MAL  A 501 ( 3.8A)
MAL  A 501 (-3.0A)
MAL  A 501 (-4.2A)
MAL  A 501 (-3.3A)
None
 0.80A 3jyrA-5gppA:
44.2		 3jyrA-5gppA:
78.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5gpp MALTOSE-BINDING
PERIPLASMIC
PROTEIN,APOPTOSIS-AS
SOCIATED SPECK-LIKE
PROTEIN CONTAINING A
CARD

(Danio rerio;
Escherichia
coli) 		PF02758
(PYRIN)
PF13416
(SBP_bac_8) 		9 ASP A  15
LYS A  16
GLU A  45
GLU A  46
ALA A  64
ASP A  66
GLU A 112
PRO A 155
TRP A 231
 MAL  A 501 (-3.4A)
MAL  A 501 (-3.1A)
None
None
MAL  A 501 ( 3.8A)
MAL  A 501 (-3.0A)
MAL  A 501 (-3.3A)
MAL  A 501 (-3.8A)
None
 0.64A 3jyrA-5gppA:
44.2		 3jyrA-5gppA:
78.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5gpp MALTOSE-BINDING
PERIPLASMIC
PROTEIN,APOPTOSIS-AS
SOCIATED SPECK-LIKE
PROTEIN CONTAINING A
CARD

(Danio rerio;
Escherichia
coli) 		PF02758
(PYRIN)
PF13416
(SBP_bac_8) 		10 ASP A  15
LYS A  43
GLU A  45
GLU A  46
ALA A  64
ASP A  66
ARG A  67
GLU A 112
TRP A 231
TYR A 342
 MAL  A 501 (-3.4A)
None
None
None
MAL  A 501 ( 3.8A)
MAL  A 501 (-3.0A)
MAL  A 501 (-4.2A)
MAL  A 501 (-3.3A)
None
None
 0.79A 3jyrA-5gppA:
44.2		 3jyrA-5gppA:
78.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5gpp MALTOSE-BINDING
PERIPLASMIC
PROTEIN,APOPTOSIS-AS
SOCIATED SPECK-LIKE
PROTEIN CONTAINING A
CARD

(Danio rerio;
Escherichia
coli) 		PF02758
(PYRIN)
PF13416
(SBP_bac_8) 		10 ASP A  15
LYS A  43
GLU A  45
GLU A  46
ALA A  64
ASP A  66
GLU A 112
PRO A 155
TRP A 231
TYR A 342
 MAL  A 501 (-3.4A)
None
None
None
MAL  A 501 ( 3.8A)
MAL  A 501 (-3.0A)
MAL  A 501 (-3.3A)
MAL  A 501 (-3.8A)
None
None
 0.60A 3jyrA-5gppA:
44.2		 3jyrA-5gppA:
78.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5h7n NLRP12-PYD WITH MBP
TAG

(Homo sapiens) 		PF02758
(PYRIN)
PF13416
(SBP_bac_8) 		12 ASP A  15
LYS A  16
LYS A  43
GLU A  45
GLU A  46
ALA A  64
ASP A  66
ARG A  67
GLU A 112
PRO A 155
TRP A 231
TYR A 342
 MTT  A 501 (-3.1A)
MTT  A 501 (-2.8A)
MTT  A 501 (-3.0A)
MTT  A 501 (-3.0A)
MTT  A 501 (-3.5A)
MTT  A 501 (-3.3A)
MTT  A 501 (-2.8A)
MTT  A 501 (-3.9A)
MTT  A 501 (-2.9A)
MTT  A 501 (-3.6A)
MTT  A 501 (-4.4A)
MTT  A 501 (-4.5A)
 0.28A 3jyrA-5h7nA:
59.2		 3jyrA-5h7nA:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5hz7 COMP

(Neisseria
meningitidis) 		PF13416
(SBP_bac_8)
PF16732
(ComP_DUS) 		12 ASP A  15
LYS A  16
LYS A  43
GLU A  45
GLU A  46
ALA A  64
ASP A  66
ARG A  67
GLU A 112
PRO A 155
TRP A 231
TYR A 342
 MLR  A 501 (-2.2A)
MLR  A 501 (-2.6A)
BGC  A 504 (-2.5A)
BGC  A 504 ( 2.4A)
BGC  A 504 (-2.2A)
MLR  A 501 (-3.0A)
MLR  A 501 (-2.8A)
MLR  A 501 (-3.8A)
MLR  A 501 (-2.4A)
MLR  A 501 (-2.6A)
MLR  A 501 (-3.3A)
MLR  A 501 ( 3.4A)
 0.30A 3jyrA-5hz7A:
62.8		 3jyrA-5hz7A:
66.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5hzv MALTOSE-BINDING
PERIPLASMIC
PROTEIN,ENDOGLIN

(Escherichia
coli;
Homo sapiens) 		PF00100
(Zona_pellucida)
PF13416
(SBP_bac_8) 		9 ASP A 381
LYS A 382
LYS A 409
GLU A 411
GLU A 412
ALA A 430
ASP A 432
ARG A 433
GLU A 478
 MAL  A1001 (-3.9A)
MAL  A1001 (-3.3A)
None
None
None
MAL  A1001 (-3.2A)
MAL  A1001 (-2.8A)
MAL  A1001 (-4.0A)
MAL  A1001 (-3.1A)
 0.95A 3jyrA-5hzvA:
61.5		 3jyrA-5hzvA:
81.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5hzv MALTOSE-BINDING
PERIPLASMIC
PROTEIN,ENDOGLIN

(Escherichia
coli;
Homo sapiens) 		PF00100
(Zona_pellucida)
PF13416
(SBP_bac_8) 		10 ASP A 381
LYS A 382
LYS A 409
GLU A 411
GLU A 412
ALA A 430
ASP A 432
GLU A 478
PRO A 521
TRP A 597
 MAL  A1001 (-3.9A)
MAL  A1001 (-3.3A)
None
None
None
MAL  A1001 (-3.2A)
MAL  A1001 (-2.8A)
MAL  A1001 (-3.1A)
MAL  A1001 (-3.9A)
MAL  A1001 (-4.8A)
 0.76A 3jyrA-5hzvA:
61.5		 3jyrA-5hzvA:
81.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ii5 MALTOSE-BINDING
PERIPLASMIC
PROTEIN,VITELLINE
ENVELOPE SPERM LYSIN
RECEPTOR

(Escherichia
coli;
Haliotis
rufescens) 		PF11386
(VERL)
PF13416
(SBP_bac_8) 		10 ASP A3681
LYS A3682
LYS A3709
GLU A3711
GLU A3712
ALA A3730
ASP A3732
ARG A3733
GLU A3778
TRP A3897
 MAL  A4201 (-2.6A)
MAL  A4201 (-2.3A)
None
None
None
MAL  A4201 (-3.2A)
MAL  A4201 (-2.5A)
MAL  A4201 (-3.8A)
MAL  A4201 (-3.0A)
MAL  A4201 ( 3.3A)
 0.65A 3jyrA-5ii5A:
37.7		 3jyrA-5ii5A:
68.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ii5 MALTOSE-BINDING
PERIPLASMIC
PROTEIN,VITELLINE
ENVELOPE SPERM LYSIN
RECEPTOR

(Escherichia
coli;
Haliotis
rufescens) 		PF11386
(VERL)
PF13416
(SBP_bac_8) 		10 ASP A3681
LYS A3682
LYS A3709
GLU A3711
GLU A3712
ALA A3730
ASP A3732
GLU A3778
PRO A3821
TRP A3897
 MAL  A4201 (-2.6A)
MAL  A4201 (-2.3A)
None
None
None
MAL  A4201 (-3.2A)
MAL  A4201 (-2.5A)
MAL  A4201 (-3.0A)
MAL  A4201 (-3.0A)
MAL  A4201 ( 3.3A)
 0.46A 3jyrA-5ii5A:
37.7		 3jyrA-5ii5A:
68.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5iic MALTOSE-BINDING
PERIPLASMIC
PROTEIN,VITELLINE
ENVELOPE SPERM LYSIN
RECEPTOR

(Escherichia
coli;
Haliotis
rufescens) 		PF11386
(VERL)
PF13416
(SBP_bac_8) 		10 ASP A3983
LYS A3984
LYS A4011
GLU A4013
GLU A4014
ALA A4032
ASP A4034
ARG A4035
GLU A4080
TRP A4199
 MAL  A4501 (-3.0A)
MAL  A4501 (-2.7A)
None
None
None
MAL  A4501 (-3.3A)
MAL  A4501 (-2.3A)
MAL  A4501 (-3.7A)
MAL  A4501 (-2.7A)
MAL  A4501 ( 3.7A)
 0.98A 3jyrA-5iicA:
56.3		 3jyrA-5iicA:
72.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5iic MALTOSE-BINDING
PERIPLASMIC
PROTEIN,VITELLINE
ENVELOPE SPERM LYSIN
RECEPTOR

(Escherichia
coli;
Haliotis
rufescens) 		PF11386
(VERL)
PF13416
(SBP_bac_8) 		10 ASP A3983
LYS A3984
LYS A4011
GLU A4013
GLU A4014
ALA A4032
ASP A4034
GLU A4080
PRO A4123
TRP A4199
 MAL  A4501 (-3.0A)
MAL  A4501 (-2.7A)
None
None
None
MAL  A4501 (-3.3A)
MAL  A4501 (-2.3A)
MAL  A4501 (-2.7A)
MAL  A4501 (-2.8A)
MAL  A4501 ( 3.7A)
 0.76A 3jyrA-5iicA:
56.3		 3jyrA-5iicA:
72.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5jj4 MALTOSE-BINDING
PERIPLASMIC
PROTEIN,SINGLE-STRAN
DED DNA CYTOSINE
DEAMINASE

(Escherichia
coli;
Homo sapiens) 		no annotation 12 ASP C  14
LYS C  15
LYS C  42
GLU C  44
GLU C  45
ALA C  63
ASP C  65
ARG C  66
GLU C 111
PRO C 154
TRP C 230
TYR C 341
 MTT  C1203 (-3.2A)
MTT  C1203 (-2.8A)
MTT  C1203 (-3.5A)
MTT  C1203 (-3.1A)
MTT  C1203 (-3.4A)
MTT  C1203 (-3.3A)
MTT  C1203 (-3.0A)
MTT  C1203 (-4.3A)
MTT  C1203 (-3.0A)
MTT  C1203 (-3.6A)
MTT  C1203 (-4.5A)
MTT  C1203 (-4.5A)
 0.55A 3jyrA-5jj4C:
61.4		 3jyrA-5jj4C:
72.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5jon MALTOSE-BINDING
PERIPLASMIC
PROTEIN,POTASSIUM/SO
DIUM
HYPERPOLARIZATION-AC
TIVATED CYCLIC
NUCLEOTIDE-GATED
CHANNEL 2

(Escherichia
coli;
Mus musculus) 		PF00027
(cNMP_binding)
PF13416
(SBP_bac_8) 		9 ASP A-355
LYS A-354
GLU A-325
GLU A-324
ALA A-306
ASP A-304
ARG A-303
GLU A-258
TRP A-139
 MAL  A 701 (-2.7A)
MAL  A 701 (-2.8A)
None
None
MAL  A 701 (-3.3A)
MAL  A 701 (-2.8A)
MAL  A 701 (-3.8A)
MAL  A 701 (-2.9A)
MAL  A 701 ( 4.5A)
 0.78A 3jyrA-5jonA:
62.0		 3jyrA-5jonA:
65.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5jon MALTOSE-BINDING
PERIPLASMIC
PROTEIN,POTASSIUM/SO
DIUM
HYPERPOLARIZATION-AC
TIVATED CYCLIC
NUCLEOTIDE-GATED
CHANNEL 2

(Escherichia
coli;
Mus musculus) 		PF00027
(cNMP_binding)
PF13416
(SBP_bac_8) 		9 ASP A-355
LYS A-354
GLU A-325
GLU A-324
ALA A-306
ASP A-304
GLU A-258
PRO A-215
TRP A-139
 MAL  A 701 (-2.7A)
MAL  A 701 (-2.8A)
None
None
MAL  A 701 (-3.3A)
MAL  A 701 (-2.8A)
MAL  A 701 (-2.9A)
MAL  A 701 (-3.4A)
MAL  A 701 ( 4.5A)
 0.49A 3jyrA-5jonA:
62.0		 3jyrA-5jonA:
65.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5osq MALTOSE-BINDING
PERIPLASMIC
PROTEIN,ZONA
PELLUCIDA
SPERM-BINDING
PROTEIN 3

(Escherichia
coli;
Mus musculus) 		PF00100
(Zona_pellucida)
PF13416
(SBP_bac_8) 		9 ASP A  15
LYS A  16
GLU A  45
GLU A  46
ALA A  64
ASP A  66
ARG A  67
GLU A 112
TRP A 231
 MAL  A 501 (-2.5A)
MAL  A 501 (-2.1A)
None
None
MAL  A 501 (-3.0A)
MAL  A 501 (-2.4A)
MAL  A 501 (-4.0A)
MAL  A 501 (-2.9A)
MAL  A 501 ( 3.3A)
 0.62A 3jyrA-5osqA:
56.7		 3jyrA-5osqA:
75.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5osq MALTOSE-BINDING
PERIPLASMIC
PROTEIN,ZONA
PELLUCIDA
SPERM-BINDING
PROTEIN 3

(Escherichia
coli;
Mus musculus) 		PF00100
(Zona_pellucida)
PF13416
(SBP_bac_8) 		9 ASP A  15
LYS A  16
GLU A  45
GLU A  46
ALA A  64
ASP A  66
GLU A 112
PRO A 155
TRP A 231
 MAL  A 501 (-2.5A)
MAL  A 501 (-2.1A)
None
None
MAL  A 501 (-3.0A)
MAL  A 501 (-2.4A)
MAL  A 501 (-2.9A)
MAL  A 501 (-3.0A)
MAL  A 501 ( 3.3A)
 0.30A 3jyrA-5osqA:
56.7		 3jyrA-5osqA:
75.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t03 MALTOSE BINDING
PROTEIN - HEPARAN
SULFATE
6-O-SULFOTRANSFERASE
ISOFORM 3 FUSION
PROTEIN

(Danio rerio;
Escherichia
coli) 		PF03567
(Sulfotransfer_2)
PF13416
(SBP_bac_8) 		12 ASP A  14
LYS A  15
LYS A  42
GLU A  44
GLU A  45
ALA A  63
ASP A  65
ARG A  66
GLU A 111
PRO A 154
TRP A 230
TYR A 341
 GLC  A1412 ( 3.0A)
GLC  A1412 ( 2.7A)
GLC  A1409 (-3.3A)
GLC  A1409 ( 2.9A)
GLC  A1409 ( 3.7A)
GLC  A1411 ( 3.2A)
GLC  A1411 (-2.7A)
GLC  A1410 (-3.8A)
GLC  A1412 (-3.0A)
GLC  A1411 ( 3.6A)
GLC  A1412 ( 4.4A)
GLC  A1410 (-4.6A)
 0.30A 3jyrA-5t03A:
62.7		 3jyrA-5t03A:
56.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5tj2 SUGAR ABC
TRANSPORTER
SUBSTRATE-BINDING
PROTEIN,GASDERMIN-B
FUSION PROTEIN

(Escherichia
coli;
Homo sapiens) 		PF04598
(Gasdermin)
PF13416
(SBP_bac_8) 		10 ASP A  14
LYS A  15
GLU A  44
GLU A  45
ALA A  63
ASP A  65
GLU A 111
PRO A 154
TRP A 230
TYR A 341
 MAL  A1501 (-3.2A)
MAL  A1501 (-2.7A)
None
None
MAL  A1501 (-3.5A)
MAL  A1501 (-2.8A)
MAL  A1501 (-3.0A)
MAL  A1501 (-3.6A)
MAL  A1501 ( 4.6A)
None
 0.41A 3jyrA-5tj2A:
61.5		 3jyrA-5tj2A:
85.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ttd MALTOSE-BINDING
PERIPLASMIC
PROTEIN,PILIN
ISOPEPTIDE LINKAGE
DOMAIN PROTEIN

(Escherichia
coli;
Streptococcus
pyogenes) 		PF12892
(FctA)
PF13416
(SBP_bac_8) 		10 ASP A  20
LYS A  21
GLU A  50
GLU A  51
ALA A  69
ASP A  71
ARG A  72
GLU A 117
PRO A 160
TRP A 236
 MLR  A 501 (-3.0A)
MLR  A 501 (-2.5A)
MLR  A 501 (-3.9A)
MLR  A 501 (-3.8A)
MLR  A 501 (-3.3A)
MLR  A 501 (-2.8A)
MLR  A 501 (-3.6A)
MLR  A 501 (-2.8A)
MLR  A 501 (-3.6A)
MLR  A 501 ( 4.6A)
 0.35A 3jyrA-5ttdA:
61.3		 3jyrA-5ttdA:
66.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5v6y MALTOSE-BINDING
PERIPLASMIC
PROTEIN,RECEPTOR
ACTIVITY-MODIFYING
PROTEIN 1,CALCITONIN
GENE-RELATED PEPTIDE
TYPE 1 RECEPTOR

(Escherichia
coli;
Homo sapiens) 		no annotation 10 ASP A  16
LYS A  17
LYS A  44
GLU A  46
GLU A  47
ALA A  65
ASP A  67
ARG A  68
GLU A 113
TRP A 232
 MAL  A2201 (-3.2A)
MAL  A2201 (-2.7A)
None
None
None
MAL  A2201 (-3.3A)
MAL  A2201 (-2.5A)
MAL  A2201 (-3.9A)
MAL  A2201 (-3.2A)
MAL  A2201 ( 4.8A)
 0.63A 3jyrA-5v6yA:
61.8		 3jyrA-5v6yA:
75.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5v6y MALTOSE-BINDING
PERIPLASMIC
PROTEIN,RECEPTOR
ACTIVITY-MODIFYING
PROTEIN 1,CALCITONIN
GENE-RELATED PEPTIDE
TYPE 1 RECEPTOR

(Escherichia
coli;
Homo sapiens) 		no annotation 10 ASP A  16
LYS A  17
LYS A  44
GLU A  46
GLU A  47
ALA A  65
ASP A  67
GLU A 113
PRO A 156
TRP A 232
 MAL  A2201 (-3.2A)
MAL  A2201 (-2.7A)
None
None
None
MAL  A2201 (-3.3A)
MAL  A2201 (-2.5A)
MAL  A2201 (-3.2A)
MAL  A2201 (-3.7A)
MAL  A2201 ( 4.8A)
 0.43A 3jyrA-5v6yA:
61.8		 3jyrA-5v6yA:
75.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5wq6 MBP TAGGED HMNDA-PYD

(Homo sapiens) 		PF02758
(PYRIN)
PF13416
(SBP_bac_8) 		10 ASP A  15
LYS A  16
LYS A  43
GLU A  45
GLU A  46
ALA A  64
ASP A  66
ARG A  67
GLU A 112
TRP A 231
 MAL  A 501 (-2.9A)
MAL  A 501 (-2.8A)
None
EDO  A 503 (-2.9A)
None
MAL  A 501 (-3.3A)
MAL  A 501 (-2.8A)
MAL  A 501 (-3.9A)
MAL  A 501 (-2.9A)
MAL  A 501 ( 4.5A)
 0.75A 3jyrA-5wq6A:
63.3		 3jyrA-5wq6A:
76.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5wq6 MBP TAGGED HMNDA-PYD

(Homo sapiens) 		PF02758
(PYRIN)
PF13416
(SBP_bac_8) 		10 ASP A  15
LYS A  16
LYS A  43
GLU A  45
GLU A  46
ALA A  64
ASP A  66
GLU A 112
PRO A 155
TRP A 231
 MAL  A 501 (-2.9A)
MAL  A 501 (-2.8A)
None
EDO  A 503 (-2.9A)
None
MAL  A 501 (-3.3A)
MAL  A 501 (-2.8A)
MAL  A 501 (-2.9A)
MAL  A 501 (-3.4A)
MAL  A 501 ( 4.5A)
 0.42A 3jyrA-5wq6A:
63.3		 3jyrA-5wq6A:
76.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6anv ANTI-CRISPR PROTEIN
ACRF1 FUSED WITH
C-TERMINAL MBP TAG

(Escherichia
coli;
Pseudomonas
phage JBD30) 		no annotation 12 ASP A  94
LYS A  95
LYS A 122
GLU A 124
GLU A 125
ALA A 143
ASP A 145
ARG A 146
GLU A 191
PRO A 234
TRP A 310
TYR A 421
 MTT  A 501 ( 3.0A)
MTT  A 501 (-2.7A)
MES  A 502 (-3.7A)
MTT  A 501 (-3.1A)
MTT  A 501 (-3.5A)
MTT  A 501 (-3.2A)
MTT  A 501 (-2.9A)
MTT  A 501 (-4.0A)
MTT  A 501 (-2.7A)
MTT  A 501 (-3.4A)
MTT  A 501 (-4.3A)
MTT  A 501 (-4.5A)
 0.23A 3jyrA-6anvA:
62.4		 3jyrA-6anvA:
80.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6dm8 -

(-) 		no annotation 9 ASP A-201
LYS A-200
GLU A-171
GLU A-170
ALA A-152
ASP A-150
GLU A-104
PRO A -61
TRP A  15
 MAL  A 402 (-3.1A)
MAL  A 402 (-2.8A)
None
None
MAL  A 402 (-3.4A)
MAL  A 402 (-2.9A)
MAL  A 402 (-3.0A)
MAL  A 402 (-3.5A)
MAL  A 402 (-4.4A)
 0.44A 3jyrA-6dm8A:
60.4		 3jyrA-6dm8A:
undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hsj FUSION PROTEIN
CONSISTING OF
STAPHYLOCOCCUS
ACCESSORY REGULATOR
PROTEIN R AND
MALTOSE BINDING
PROTEIN

(Escherichia
coli;
Staphylococcus
aureus) 		PF01547
(SBP_bac_1) 		6 ASN A  12
TRP A  62
GLU A 153
TYR A 155
MET A 330
TRP A 340
 GLC  A 672 (-3.9A)
GLC  A 671 (-4.1A)
GLC  A 671 (-4.3A)
GLC  A 671 ( 4.1A)
GLC  A 671 ( 4.3A)
GLC  A 671 (-3.4A)
 0.34A 3jyrA-1hsjA:
61.1		 3jyrA-1hsjA:
87.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1mg1 PROTEIN (HTLV-1 GP21
ECTODOMAIN/MALTOSE-B
INDING PROTEIN
CHIMERA)

(Primate
T-lymphotropic
virus 1) 		PF00429
(TLV_coat)
PF13416
(SBP_bac_8) 		6 ASN A  13
TRP A  63
GLU A 154
TYR A 156
MET A 331
TRP A 341
 MAL  A 456 (-4.4A)
MAL  A 456 (-4.3A)
MAL  A 456 (-4.0A)
MAL  A 456 (-3.8A)
MAL  A 456 ( 4.2A)
MAL  A 456 (-3.9A)
 0.33A 3jyrA-1mg1A:
59.7		 3jyrA-1mg1A:
79.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1mg1 PROTEIN (HTLV-1 GP21
ECTODOMAIN/MALTOSE-B
INDING PROTEIN
CHIMERA)

(Primate
T-lymphotropic
virus 1) 		PF00429
(TLV_coat)
PF13416
(SBP_bac_8) 		4 TYR A 156
MET A 331
TRP A 341
ARG A 345
 MAL  A 456 (-3.8A)
MAL  A 456 ( 4.2A)
MAL  A 456 (-3.9A)
None
 0.83A 3jyrA-1mg1A:
59.7		 3jyrA-1mg1A:
79.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1r6z CHIMERA OF
MALTOSE-BINDING
PERIPLASMIC PROTEIN
AND ARGONAUTE 2

(Drosophila
melanogaster;
Escherichia
coli) 		no annotation 6 ASN P  11
TRP P  61
GLU P 152
TYR P 154
MET P 329
TRP P 339
 MAL  P 727 (-4.4A)
MAL  P 727 (-4.3A)
MAL  P 727 (-3.6A)
MAL  P 727 (-3.7A)
MAL  P 727 ( 4.3A)
MAL  P 727 (-3.5A)
 0.31A 3jyrA-1r6zP:
61.8		 3jyrA-1r6zP:
72.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1y4c MALTOSE BINDING
PROTEIN FUSED WITH
DESIGNED HELICAL
PROTEIN

(Escherichia
coli) 		PF13416
(SBP_bac_8) 		6 ASN A  12
TRP A  62
GLU A 153
TYR A 155
MET A 330
TRP A 340
 GLC  A 371 (-4.4A)
GLC  A 372 (-4.3A)
GLC  A 372 ( 3.7A)
GLC  A 371 (-3.9A)
GLC  A 372 ( 4.3A)
GLC  A 372 (-3.6A)
 0.22A 3jyrA-1y4cA:
62.4		 3jyrA-1y4cA:
70.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1y4c MALTOSE BINDING
PROTEIN FUSED WITH
DESIGNED HELICAL
PROTEIN

(Escherichia
coli) 		PF13416
(SBP_bac_8) 		5 TRP A  62
TYR A 155
MET A 330
TRP A 340
ARG A 344
 GLC  A 372 (-4.3A)
GLC  A 371 (-3.9A)
GLC  A 372 ( 4.3A)
GLC  A 372 (-3.6A)
None
 0.58A 3jyrA-1y4cA:
62.4		 3jyrA-1y4cA:
70.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2nvu MALTOSE BINDING
PROTEIN/NEDD8-ACTIVA
TING ENZYME E1
CATALYTIC SUBUNIT
CHIMERA

(Homo sapiens) 		PF00899
(ThiF)
PF08825
(E2_bind)
PF13416
(SBP_bac_8) 		4 GLU B1154
TYR B1156
MET B1331
TRP B1341
 None
 0.79A 3jyrA-2nvuB:
45.8		 3jyrA-2nvuB:
42.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2oeh AT-RICH INTERACTIVE
DOMAIN-CONTAINING
PROTEIN 5B

(Homo sapiens) 		PF01388
(ARID) 		4 GLU A  82
TYR A  81
TRP A  57
ARG A  79
 None
 0.76A 3jyrA-2oehA:
undetectable		 3jyrA-2oehA:
13.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2vgq SUGAR ABC
TRANSPORTER
SUBSTRATE-BINDING
PROTEIN,MITOCHONDRIA
L
ANTIVIRAL-SIGNALING
PROTEIN

(Escherichia
coli;
Homo sapiens) 		PF13416
(SBP_bac_8)
PF16739
(CARD_2) 		7 ASN A  12
TRP A  62
GLU A 153
TYR A 155
MET A 330
TRP A 340
ARG A 344
 MTT  A1463 ( 4.8A)
MTT  A1463 (-4.2A)
MTT  A1463 (-3.1A)
MTT  A1463 (-3.7A)
MTT  A1463 ( 4.4A)
MTT  A1463 (-3.9A)
MTT  A1463 (-3.5A)
 0.14A 3jyrA-2vgqA:
63.1		 3jyrA-2vgqA:
79.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2xz3 MALTOSE ABC
TRANSPORTER
PERIPLASMIC PROTEIN,
ENVELOPE
GLYCOPROTEIN

(Bovine leukemia
virus;
Escherichia
coli) 		PF00429
(TLV_coat)
PF13416
(SBP_bac_8) 		6 ASN A  38
TRP A  88
GLU A 179
TYR A 181
MET A 356
TRP A 366
 MAL  A1488 (-4.6A)
MAL  A1488 (-4.5A)
MAL  A1488 (-3.6A)
MAL  A1488 (-3.8A)
MAL  A1488 (-4.4A)
MAL  A1488 (-3.8A)
 0.16A 3jyrA-2xz3A:
62.4		 3jyrA-2xz3A:
83.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3a3c MALTOSE-BINDING
PERIPLASMIC PROTEIN,
LINKER,
MITOCHONDRIAL
INTERMEMBRANE SPACE
IMPORT AND ASSEMBLY
PROTEIN 40

(Escherichia
coli;
Saccharomyces
cerevisiae;
synthetic
construct) 		PF06747
(CHCH)
PF13416
(SBP_bac_8) 		6 ASN A  12
TRP A  62
GLU A 153
TYR A 155
MET A 330
TRP A 340
 None
MAL  A 466 (-3.6A)
MAL  A 466 (-3.6A)
MAL  A 466 (-4.2A)
None
MAL  A 466 (-2.6A)
 0.25A 3jyrA-3a3cA:
60.2		 3jyrA-3a3cA:
77.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3csg MALTOSE-BINDING
PROTEIN MONOBODY YS1
FUSION

(Escherichia
coli) 		PF00041
(fn3)
PF13416
(SBP_bac_8) 		4 GLU A 153
TYR A 155
MET A 330
TRP A 340
 None
 0.81A 3jyrA-3csgA:
36.7		 3jyrA-3csgA:
88.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3dm0 MALTOSE-BINDING
PERIPLASMIC PROTEIN
FUSED WITH RACK1

(Arabidopsis
thaliana;
Escherichia
coli) 		PF00400
(WD40)
PF01547
(SBP_bac_1) 		6 ASN A  12
TRP A  62
GLU A 153
TYR A 155
MET A 330
TRP A 340
 GLC  A 672 ( 4.5A)
GLC  A 671 (-4.7A)
EDO  A 401 (-3.4A)
GLC  A 672 (-3.9A)
GLC  A 671 ( 4.4A)
GLC  A 671 (-3.7A)
 0.20A 3jyrA-3dm0A:
62.1		 3jyrA-3dm0A:
52.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ehs FUSION PROTEIN OF
CRFR1 EXTRACELLULAR
DOMAIN AND MBP

(Escherichia
coli;
Homo sapiens) 		PF02793
(HRM)
PF13416
(SBP_bac_8) 		6 ASN A-337
TRP A-287
GLU A-196
TYR A-194
MET A -19
TRP A  -9
 MAL  A 126 (-4.0A)
MAL  A 126 (-4.4A)
MAL  A 126 (-3.8A)
MAL  A 126 (-4.1A)
MAL  A 126 ( 4.3A)
MAL  A 126 (-3.7A)
 0.22A 3jyrA-3ehsA:
61.2		 3jyrA-3ehsA:
72.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3f5f MALTOSE-BINDING
PERIPLASMIC PROTEIN,
HEPARAN SULFATE
2-O-SULFOTRANSFERASE
1

(Escherichia
coli;
Gallus gallus) 		PF03567
(Sulfotransfer_2)
PF13416
(SBP_bac_8) 		6 ASN A  12
TRP A  62
GLU A 153
TYR A 155
MET A 330
TRP A 340
 GLC  A 672 (-4.5A)
GLC  A 671 (-4.5A)
GLC  A 672 ( 4.2A)
GLC  A 672 (-3.8A)
GLC  A 671 ( 4.3A)
GLC  A 671 (-3.8A)
 0.28A 3jyrA-3f5fA:
60.3		 3jyrA-3f5fA:
57.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3h4z MALTOSE-BINDING
PERIPLASMIC PROTEIN
FUSED WITH ALLERGEN
DERP7

(Dermatophagoides
pteronyssinus;
Escherichia
coli) 		PF13416
(SBP_bac_8)
PF16984
(Grp7_allergen) 		6 ASN A  12
TRP A  62
GLU A 153
TYR A 155
MET A 330
TRP A 340
 GLC  A 672 (-4.0A)
GLC  A 671 (-4.4A)
GLC  A 671 ( 3.7A)
GLC  A 672 (-3.9A)
GLC  A 671 ( 4.4A)
GLC  A 671 (-3.6A)
 0.27A 3jyrA-3h4zA:
62.1		 3jyrA-3h4zA:
62.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3h4z MALTOSE-BINDING
PERIPLASMIC PROTEIN
FUSED WITH ALLERGEN
DERP7

(Dermatophagoides
pteronyssinus;
Escherichia
coli) 		PF13416
(SBP_bac_8)
PF16984
(Grp7_allergen) 		6 ASN A  12
TRP A  62
TYR A 155
MET A 330
TRP A 340
ARG A 344
 GLC  A 672 (-4.0A)
GLC  A 671 (-4.4A)
GLC  A 672 (-3.9A)
GLC  A 671 ( 4.4A)
GLC  A 671 (-3.6A)
None
 0.63A 3jyrA-3h4zA:
62.1		 3jyrA-3h4zA:
62.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3l2j FUSION PROTEIN OF
MALTOSE-BINDING
PERIPLASMIC PROTEIN
AND PARATHYROID
HORMONE/PARATHYROID
HORMONE-RELATED
PEPTIDE RECEPTOR

(Escherichia
coli;
Homo sapiens) 		PF02793
(HRM)
PF13416
(SBP_bac_8) 		6 ASN A-332
TRP A-282
GLU A-191
TYR A-189
MET A -14
TRP A  -4
 MAL  A 194 (-4.1A)
MAL  A 194 (-4.2A)
MAL  A 194 (-3.9A)
MAL  A 194 (-4.1A)
MAL  A 194 ( 4.1A)
MAL  A 194 (-3.6A)
 0.54A 3jyrA-3l2jA:
53.8		 3jyrA-3l2jA:
67.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mp6 MALTOSE-BINDING
PERIPLASMIC
PROTEIN,LINKER,SAGA-
ASSOCIATED FACTOR 29

(Escherichia
coli;
Saccharomyces
cerevisiae;
unidentified) 		PF07039
(DUF1325)
PF13416
(SBP_bac_8) 		6 ASN A 750
TRP A 800
GLU A 891
TYR A 893
MET A1068
TRP A1078
 MAL  A 600 ( 4.7A)
MAL  A 600 (-4.3A)
MAL  A 600 (-3.8A)
MAL  A 600 (-3.8A)
MAL  A 600 ( 4.2A)
MAL  A 600 (-3.6A)
 0.24A 3jyrA-3mp6A:
62.3		 3jyrA-3mp6A:
63.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3n93 MALTOSE BINDING
PROTEIN-CRFR2 ALPHA

(Homo sapiens) 		PF02793
(HRM)
PF13416
(SBP_bac_8) 		6 ASN A-358
TRP A-308
GLU A-217
TYR A-215
MET A -40
TRP A -30
 MAL  A 111 (-4.4A)
MAL  A 111 (-4.4A)
MAL  A 111 (-3.7A)
MAL  A 111 (-3.9A)
MAL  A 111 ( 4.4A)
MAL  A 111 (-3.6A)
 0.24A 3jyrA-3n93A:
61.9		 3jyrA-3n93A:
68.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3n94 FUSION PROTEIN OF
MALTOSE-BINDING
PERIPLASMIC PROTEIN
AND PITUITARY
ADENYLATE CYCLASE 1
RECEPTOR-SHORT

(Escherichia
coli;
Homo sapiens) 		PF02793
(HRM)
PF13416
(SBP_bac_8) 		6 ASN A-336
TRP A-286
GLU A-195
TYR A-193
MET A -18
TRP A  -8
 MAL  A5044 ( 4.7A)
MAL  A5044 (-4.4A)
MAL  A5044 (-3.7A)
MAL  A5044 (-3.8A)
MAL  A5044 ( 4.2A)
MAL  A5044 (-3.6A)
 0.24A 3jyrA-3n94A:
57.3		 3jyrA-3n94A:
79.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3o3u MALTOSE-BINDING
PERIPLASMIC PROTEIN,
ADVANCED
GLYCOSYLATION END
PRODUCT-SPECIFIC
RECEPTOR

(Escherichia
coli;
Homo sapiens) 		PF08205
(C2-set_2)
PF13416
(SBP_bac_8) 		7 ASN N  12
TRP N  62
GLU N 153
TYR N 155
MET N 330
TRP N 340
ARG N 344
 MLR  N2001 ( 4.7A)
MLR  N2001 (-4.3A)
MLR  N2001 (-3.2A)
MLR  N2001 (-3.8A)
MLR  N2001 ( 4.3A)
MLR  N2001 (-3.8A)
None
 0.18A 3jyrA-3o3uN:
63.3		 3jyrA-3o3uN:
71.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3oai MALTOSE-BINDING
PERIPLASMIC PROTEIN,
MYELIN PROTEIN P0

(Escherichia
coli;
Homo sapiens) 		PF07686
(V-set)
PF13416
(SBP_bac_8) 		7 ASN A  12
TRP A  62
GLU A 153
TYR A 155
MET A 330
TRP A 340
ARG A 344
 MAL  A1122 ( 4.2A)
MAL  A1122 (-4.4A)
MAL  A1122 (-3.6A)
MAL  A1122 (-3.8A)
MAL  A1122 ( 4.1A)
MAL  A1122 (-3.7A)
None
 0.65A 3jyrA-3oaiA:
62.1		 3jyrA-3oaiA:
69.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ob4 MALTOSE ABC
TRANSPORTER
PERIPLASMIC PROTEIN,
ARAH 2

(Arachis
duranensis;
Escherichia
coli) 		PF00234
(Tryp_alpha_amyl)
PF13416
(SBP_bac_8) 		6 ASN A  12
TRP A  62
GLU A 153
TYR A 155
MET A 330
TRP A 340
 MLR  A 400 ( 4.9A)
MLR  A 400 (-4.5A)
MLR  A 400 (-2.9A)
MLR  A 400 (-4.0A)
MLR  A 400 (-4.3A)
MLR  A 400 (-3.8A)
 0.27A 3jyrA-3ob4A:
62.3		 3jyrA-3ob4A:
68.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ob4 MALTOSE ABC
TRANSPORTER
PERIPLASMIC PROTEIN,
ARAH 2

(Arachis
duranensis;
Escherichia
coli) 		PF00234
(Tryp_alpha_amyl)
PF13416
(SBP_bac_8) 		6 ASN A  12
TRP A  62
TYR A 155
MET A 330
TRP A 340
ARG A 344
 MLR  A 400 ( 4.9A)
MLR  A 400 (-4.5A)
MLR  A 400 (-4.0A)
MLR  A 400 (-4.3A)
MLR  A 400 (-3.8A)
None
 0.62A 3jyrA-3ob4A:
62.3		 3jyrA-3ob4A:
68.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3osq MALTOSE-BINDING
PERIPLASMIC
PROTEIN,GREEN
FLUORESCENT PROTEIN

(Aequorea
victoria;
Escherichia
coli) 		PF01353
(GFP)
PF01547
(SBP_bac_1)
PF13416
(SBP_bac_8) 		6 ASN A  12
TRP A  62
GLU A 153
TYR A 155
MET A 578
TRP A 588
 MAL  A 700 (-4.6A)
MAL  A 700 (-4.5A)
MAL  A 700 (-3.7A)
MAL  A 700 (-3.8A)
MAL  A 700 ( 4.3A)
MAL  A 700 (-3.8A)
 0.15A 3jyrA-3osqA:
45.3		 3jyrA-3osqA:
53.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3osr MALTOSE-BINDING
PERIPLASMIC
PROTEIN,GREEN
FLUORESCENT PROTEIN

(Aequorea
victoria;
Escherichia
coli) 		PF01353
(GFP)
PF01547
(SBP_bac_1) 		6 ASN A  12
TRP A  62
GLU A 153
TYR A 155
MET A 579
TRP A 589
 MAL  A 700 ( 4.7A)
MAL  A 700 (-4.4A)
MAL  A 700 (-3.6A)
MAL  A 700 (-3.9A)
MAL  A 700 ( 4.1A)
MAL  A 700 (-3.6A)
 0.38A 3jyrA-3osrA:
63.0		 3jyrA-3osrA:
53.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3py7 MALTOSE-BINDING
PERIPLASMIC
PROTEIN,PAXILLIN
LD1,PROTEIN E6
CHIMERA

(Deltapapillomavirus
4;
Escherichia
coli;
Homo sapiens) 		PF00518
(E6)
PF01547
(SBP_bac_1) 		7 ASN A  13
TRP A  63
GLU A 154
TYR A 156
MET A 331
TRP A 341
ARG A 345
 MLR  A 701 ( 4.6A)
MLR  A 701 (-4.4A)
MLR  A 701 (-3.2A)
MLR  A 701 (-3.8A)
MLR  A 701 ( 4.2A)
MLR  A 701 (-4.0A)
None
 0.23A 3jyrA-3py7A:
62.9		 3jyrA-3py7A:
68.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3vd8 MALTOSE-BINDING
PERIPLASMIC PROTEIN,
INTERFERON-INDUCIBLE
PROTEIN AIM2

(Escherichia
coli;
Homo sapiens) 		PF02758
(PYRIN)
PF13416
(SBP_bac_8) 		7 ASN A  12
TRP A  62
GLU A 153
TYR A 155
MET A 330
TRP A 340
ARG A 344
 MTT  A1205 (-4.6A)
MTT  A1205 (-4.4A)
MTT  A1205 (-3.4A)
MTT  A1205 (-4.0A)
MTT  A1205 ( 4.2A)
MTT  A1205 (-3.9A)
MTT  A1205 (-4.0A)
 0.55A 3jyrA-3vd8A:
62.6		 3jyrA-3vd8A:
69.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3wai MALTOSE-BINDING
PERIPLASMIC PROTEIN,
TRANSMEMBRANE
OLIGOSACCHARYL
TRANSFERASE

(Archaeoglobus
fulgidus;
Escherichia
coli) 		PF13416
(SBP_bac_8) 		4 GLU A 153
TYR A 155
MET A 330
ARG A 344
 None
 0.74A 3jyrA-3waiA:
47.6		 3jyrA-3waiA:
48.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4b3n MALTOSE-BINDING
PERIPLASMIC PROTEIN,
TRIPARTITE
MOTIF-CONTAINING
PROTEIN 5

(Escherichia
coli;
Macaca mulatta) 		PF00622
(SPRY)
PF01547
(SBP_bac_1) 		6 ASN A  12
TRP A  62
GLU A 153
TYR A 155
MET A 330
TRP A 340
 MAL  A 500 ( 4.2A)
MAL  A 500 (-4.3A)
MAL  A 500 (-3.4A)
MAL  A 500 (-3.9A)
MAL  A 500 ( 4.4A)
MAL  A 500 (-3.9A)
 0.41A 3jyrA-4b3nA:
60.8		 3jyrA-4b3nA:
71.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4b3n MALTOSE-BINDING
PERIPLASMIC PROTEIN,
TRIPARTITE
MOTIF-CONTAINING
PROTEIN 5

(Escherichia
coli;
Macaca mulatta) 		PF00622
(SPRY)
PF01547
(SBP_bac_1) 		6 ASN A  12
TRP A  62
TYR A 155
MET A 330
TRP A 340
ARG A 344
 MAL  A 500 ( 4.2A)
MAL  A 500 (-4.3A)
MAL  A 500 (-3.9A)
MAL  A 500 ( 4.4A)
MAL  A 500 (-3.9A)
None
 0.58A 3jyrA-4b3nA:
60.8		 3jyrA-4b3nA:
71.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4dxb MALTOSE-BINDING
PERIPLASMIC PROTEIN,
BETA-LACTAMASE TEM
CHIMERA

(Escherichia
coli) 		PF01547
(SBP_bac_1)
PF13354
(Beta-lactamase2) 		4 GLU A 153
TYR A 155
MET A 597
TRP A 607
 None
 0.70A 3jyrA-4dxbA:
53.6		 3jyrA-4dxbA:
54.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4edq MALTOSE-BINDING
PERIPLASMIC
PROTEIN,MYOSIN-BINDI
NG PROTEIN C,
CARDIAC-TYPE
CHIMERIC PROTEIN

(Escherichia
coli;
Mus musculus) 		PF07679
(I-set)
PF13416
(SBP_bac_8) 		6 ASN A  13
TRP A  63
GLU A 154
TYR A 156
MET A 331
TRP A 341
 MLR  A 500 (-4.6A)
MLR  A 500 (-4.2A)
MLR  A 500 (-3.0A)
MLR  A 500 (-2.9A)
MLR  A 500 ( 3.5A)
MLR  A 500 (-2.9A)
 0.22A 3jyrA-4edqA:
60.8		 3jyrA-4edqA:
71.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4egc MALTOSE-BINDING
PERIPLASMIC PROTEIN,
HOMEOBOX PROTEIN
SIX1 CHIMERA

(Escherichia
coli;
Homo sapiens) 		PF00046
(Homeobox)
PF13416
(SBP_bac_8)
PF16878
(SIX1_SD) 		6 ASN A  12
TRP A  62
GLU A 153
TYR A 155
MET A 330
TRP A 340
 MAL  A 601 (-4.6A)
MAL  A 601 (-4.3A)
MAL  A 601 (-3.8A)
MAL  A 601 (-3.9A)
MAL  A 601 ( 4.4A)
MAL  A 601 (-3.7A)
 0.21A 3jyrA-4egcA:
55.6		 3jyrA-4egcA:
63.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4exk MALTOSE-BINDING
PERIPLASMIC PROTEIN,
UNCHARACTERIZED
PROTEIN CHIMERA

(Escherichia
coli;
Salmonella
enterica) 		PF13416
(SBP_bac_8)
PF16583
(ZirS_C) 		7 ASN A  12
TRP A  62
GLU A 153
TYR A 155
MET A 330
TRP A 340
ARG A 344
 MTT  A 501 ( 4.7A)
MTT  A 501 (-4.2A)
MTT  A 501 (-3.3A)
MTT  A 501 (-3.7A)
MTT  A 501 ( 4.4A)
MTT  A 501 (-3.9A)
MTT  A 501 (-3.9A)
 0.15A 3jyrA-4exkA:
62.4		 3jyrA-4exkA:
72.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4giz MALTOSE-BINDING
PERIPLASMIC PROTEIN,
UBIQUITIN LIGASE
EA6P: CHIMERIC
PROTEIN

(Escherichia
coli;
Homo sapiens) 		PF01547
(SBP_bac_1) 		4 GLU A 154
TYR A 156
MET A 331
TRP A 341
 CEY  A 400 (-3.1A)
CEY  A 400 (-3.7A)
CEY  A 400 ( 3.9A)
CEY  A 400 (-3.8A)
 0.83A 3jyrA-4gizA:
58.3		 3jyrA-4gizA:
91.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4h1g MALTOSE BINDING
PROTEIN-CAKAR3 MOTOR
DOMAIN FUSION
PROTEIN

(Candida
albicans;
Escherichia
coli) 		PF00225
(Kinesin)
PF13416
(SBP_bac_8) 		6 ASN A-358
TRP A-308
GLU A-217
TYR A-215
MET A -40
TRP A -30
 MTT  A 701 ( 4.8A)
MTT  A 701 (-4.5A)
MTT  A 701 (-3.2A)
MTT  A 701 (-3.8A)
MTT  A 701 ( 4.1A)
MTT  A 701 (-3.8A)
 0.25A 3jyrA-4h1gA:
63.0		 3jyrA-4h1gA:
47.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4h1g MALTOSE BINDING
PROTEIN-CAKAR3 MOTOR
DOMAIN FUSION
PROTEIN

(Candida
albicans;
Escherichia
coli) 		PF00225
(Kinesin)
PF13416
(SBP_bac_8) 		6 ASN A-358
TRP A-308
TYR A-215
MET A -40
TRP A -30
ARG A -26
 MTT  A 701 ( 4.8A)
MTT  A 701 (-4.5A)
MTT  A 701 (-3.8A)
MTT  A 701 ( 4.1A)
MTT  A 701 (-3.8A)
MTT  A 701 (-3.9A)
 0.59A 3jyrA-4h1gA:
63.0		 3jyrA-4h1gA:
47.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ifp MALTOSE-BINDING
PERIPLASMIC
PROTEIN,NACHT, LRR
AND PYD
DOMAINS-CONTAINING
PROTEIN 1

(Escherichia
coli;
Homo sapiens) 		PF00619
(CARD)
PF13416
(SBP_bac_8) 		6 ASN A  13
TRP A  63
GLU A 154
TYR A 156
MET A 331
TRP A 341
 MAL  A 501 ( 4.8A)
MAL  A 501 (-4.4A)
MAL  A 501 (-3.7A)
MAL  A 501 (-3.8A)
MAL  A 501 (-4.2A)
MAL  A 501 (-3.7A)
 0.20A 3jyrA-4ifpA:
61.5		 3jyrA-4ifpA:
81.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ifp MALTOSE-BINDING
PERIPLASMIC
PROTEIN,NACHT, LRR
AND PYD
DOMAINS-CONTAINING
PROTEIN 1

(Escherichia
coli;
Homo sapiens) 		PF00619
(CARD)
PF13416
(SBP_bac_8) 		5 TRP A  63
TYR A 156
MET A 331
TRP A 341
ARG A 345
 MAL  A 501 (-4.4A)
MAL  A 501 (-3.8A)
MAL  A 501 (-4.2A)
MAL  A 501 (-3.7A)
None
 0.68A 3jyrA-4ifpA:
61.5		 3jyrA-4ifpA:
81.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ikm MALTOSE-BINDING
PERIPLASMIC PROTEIN,
CASPASE RECRUITMENT
DOMAIN-CONTAINING
PROTEIN 8

(Escherichia
coli;
Homo sapiens) 		PF00619
(CARD)
PF13416
(SBP_bac_8) 		6 ASN A  13
TRP A  63
GLU A 154
TYR A 156
MET A 331
TRP A 341
 MAL  A 501 (-4.2A)
MAL  A 501 (-4.4A)
MAL  A 501 (-3.6A)
MAL  A 501 (-4.0A)
MAL  A 501 (-4.6A)
MAL  A 501 (-3.8A)
 0.18A 3jyrA-4ikmA:
61.7		 3jyrA-4ikmA:
77.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4irl MALTOSE-BINDING
PERIPLASMIC PROTEIN,
NOVEL PROTEIN
SIMILAR TO
VERTEBRATE GUANYLATE
BINDING PROTEIN
FAMILY

(Danio rerio;
Escherichia
coli) 		PF00619
(CARD)
PF13416
(SBP_bac_8) 		7 ASN A  13
TRP A  63
GLU A 154
TYR A 156
MET A 331
TRP A 341
ARG A 345
 MTT  A 501 ( 4.8A)
MTT  A 501 (-4.4A)
MTT  A 501 (-3.5A)
MTT  A 501 (-3.8A)
MTT  A 501 ( 4.5A)
MTT  A 501 (-4.0A)
MTT  A 501 (-4.0A)
 0.15A 3jyrA-4irlA:
62.9		 3jyrA-4irlA:
77.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4keg MALTOSE-BINDING
PERIPLASMIC/PALATE
LUNG AND NASAL
EPITHELIUM CLONE
FUSION PROTEIN

(Escherichia
coli;
Homo sapiens) 		PF01273
(LBP_BPI_CETP)
PF13416
(SBP_bac_8) 		4 GLU A 153
TYR A 155
MET A 330
TRP A 340
 None
 0.73A 3jyrA-4kegA:
53.5		 3jyrA-4kegA:
64.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4kv3 CHIMERA FUSION
PROTEIN OF ESX-1
SECRETION SYSTEM
PROTEIN ECCD1 AND
MALTOSE-BINDING
PERIPLASMIC PROTEIN

(Escherichia
coli;
Mycobacterium
tuberculosis) 		PF08817
(YukD)
PF13416
(SBP_bac_8) 		6 ASN A  13
TRP A  63
GLU A 154
TYR A 156
MET A 331
TRP A 341
 MAL  A 501 (-4.4A)
MAL  A 501 (-4.5A)
MAL  A 501 (-3.6A)
MAL  A 501 (-3.9A)
MAL  A 501 ( 4.3A)
MAL  A 501 (-3.7A)
 0.23A 3jyrA-4kv3A:
61.6		 3jyrA-4kv3A:
74.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4log MALTOSE ABC
TRANSPORTER
PERIPLASMIC PROTEIN
AND NR2E3 PROTEIN
CHIMERIC CONSTRUCT

(Escherichia
coli;
Homo sapiens) 		PF00104
(Hormone_recep)
PF13416
(SBP_bac_8) 		4 GLU A 155
TYR A 157
MET A 332
TRP A 342
 None
 0.68A 3jyrA-4logA:
41.1		 3jyrA-4logA:
61.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4my2 MALTOSE-BINDING
PERIPLASMIC PROTEIN,
NORRIN FUSION
PROTEIN

(Escherichia
coli;
Homo sapiens) 		PF00007
(Cys_knot)
PF13416
(SBP_bac_8) 		6 ASN A  14
TRP A  64
GLU A 155
TYR A 157
MET A 332
TRP A 342
 MAL  A1201 (-3.9A)
MAL  A1201 (-4.3A)
MAL  A1201 (-3.6A)
MAL  A1201 (-3.9A)
MAL  A1201 ( 4.3A)
MAL  A1201 (-3.6A)
 0.27A 3jyrA-4my2A:
62.0		 3jyrA-4my2A:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4nuf MALTOSE ABC
TRANSPORTER
PERIPLASMIC PROTEIN,
NUCLEAR RECEPTOR
SUBFAMILY 0 GROUP B
MEMBER 2 CHIMERIC
CONSTRUCT

(Escherichia
coli;
Mus musculus) 		PF00104
(Hormone_recep)
PF13416
(SBP_bac_8) 		6 ASN A  14
TRP A  64
GLU A 155
TYR A 157
MET A 332
TRP A 342
 MAL  A1301 (-4.0A)
MAL  A1301 (-4.5A)
MAL  A1301 (-3.2A)
MAL  A1301 (-4.0A)
MAL  A1301 ( 4.2A)
MAL  A1301 (-3.6A)
 0.30A 3jyrA-4nufA:
55.4		 3jyrA-4nufA:
58.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4o2x MALTOSE-BINDING
PERIPLASMIC PROTEIN,
ATP-DEPENDENT CLP
PROTEASE ADAPTOR
PROTEIN CLPS
CONTAINING PROTEIN
CHIMERIC CONSTRUCT

(Escherichia
coli;
Plasmodium
falciparum) 		PF02617
(ClpS)
PF13416
(SBP_bac_8) 		4 GLU A 154
TYR A 156
MET A 331
TRP A 341
 None
 0.65A 3jyrA-4o2xA:
49.6		 3jyrA-4o2xA:
71.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ozq CHIMERA OF
MALTOSE-BINDING
PERIPLASMIC PROTEIN
AND KINESIN FAMILY
MEMBER 14 PROTEIN

(Escherichia
coli;
Mus musculus) 		PF00225
(Kinesin)
PF13416
(SBP_bac_8) 		4 GLU A-217
TYR A-215
MET A -40
TRP A -30
 None
 0.84A 3jyrA-4ozqA:
49.8		 3jyrA-4ozqA:
52.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4pe2 MALTOSE ABC
TRANSPORTER
PERIPLASMIC
PROTEIN,PREPILIN-TYP
E N-TERMINAL
CLEAVAGE/METHYLATION
DOMAIN PROTEIN

(Clostridioides
difficile;
Escherichia
coli) 		PF13416
(SBP_bac_8) 		7 ASN A  12
TRP A  62
GLU A 153
TYR A 155
MET A 330
TRP A 340
ARG A 344
 MAL  A 601 (-4.5A)
MAL  A 601 (-4.5A)
MAL  A 601 (-3.6A)
MAL  A 601 (-3.9A)
MAL  A 601 ( 4.3A)
MAL  A 601 (-3.8A)
None
 0.30A 3jyrA-4pe2A:
54.3		 3jyrA-4pe2A:
72.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4pqk MALTOSE ABC
TRANSPORTER
PERIPLASMIC PROTEIN,
TRUNCATED
REPLICATION PROTEIN
REPA

(Escherichia
coli;
Staphylococcus
aureus) 		PF13416
(SBP_bac_8) 		6 ASN A  13
TRP A  63
GLU A 154
TYR A 156
MET A 331
TRP A 341
 MLR  A 700 (-4.7A)
MLR  A 700 (-4.6A)
MLR  A 700 (-4.0A)
MLR  A 700 (-3.8A)
MLR  A 700 (-4.1A)
MLR  A 700 (-4.0A)
 0.42A 3jyrA-4pqkA:
54.4		 3jyrA-4pqkA:
76.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4qsz MALTOSE-BINDING
PERIPLASMIC PROTEIN,
JMJC
DOMAIN-CONTAINING
PROTEIN 7 CHIMERA

(Escherichia
coli;
Mus musculus) 		PF13416
(SBP_bac_8)
PF13621
(Cupin_8) 		6 ASN A-359
TRP A-309
GLU A-218
TYR A-216
MET A -41
TRP A -31
 GLC  A 901 (-4.7A)
GLC  A 902 (-3.9A)
FLC  A 903 (-3.0A)
GLC  A 901 ( 3.8A)
GLC  A 902 ( 4.1A)
GLC  A 902 ( 3.6A)
 0.19A 3jyrA-4qszA:
60.3		 3jyrA-4qszA:
50.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4qsz MALTOSE-BINDING
PERIPLASMIC PROTEIN,
JMJC
DOMAIN-CONTAINING
PROTEIN 7 CHIMERA

(Escherichia
coli;
Mus musculus) 		PF13416
(SBP_bac_8)
PF13621
(Cupin_8) 		5 GLU A-218
TYR A-216
MET A -41
TRP A -31
ARG A -27
 FLC  A 903 (-3.0A)
GLC  A 901 ( 3.8A)
GLC  A 902 ( 4.1A)
GLC  A 902 ( 3.6A)
FLC  A 903 (-2.9A)
 0.90A 3jyrA-4qszA:
60.3		 3jyrA-4qszA:
50.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4qvh MALTOSE-BINDING
PERIPLASMIC PROTEIN,
4'-PHOSPHOPANTETHEIN
YL TRANSFERASE
CHIMERA

(Escherichia
coli;
Mycobacterium
tuberculosis) 		PF01648
(ACPS)
PF13416
(SBP_bac_8) 		6 ASN A  13
TRP A  63
GLU A 154
TYR A 156
MET A 331
TRP A 341
 MAL  A 601 ( 4.6A)
MAL  A 601 (-4.3A)
MAL  A 601 (-3.6A)
MAL  A 601 (-3.9A)
MAL  A 601 ( 4.4A)
MAL  A 601 (-3.6A)
 0.24A 3jyrA-4qvhA:
62.0		 3jyrA-4qvhA:
61.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4r0y MALTOSE-BINDING
PERIPLASMIC PROTEIN,
DISKS
LARGE-ASSOCIATED
PROTEIN 1

(Escherichia
coli;
Rattus
norvegicus) 		PF03359
(GKAP)
PF13416
(SBP_bac_8) 		4 GLU A 153
TYR A 155
MET A 330
TRP A 340
 None
 0.75A 3jyrA-4r0yA:
47.8		 3jyrA-4r0yA:
75.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4rwf MALTOSE TRANSPORTER
SUBUNIT, RECEPTOR
ACTIVITY-MODIFYING
PROTEIN 2,
CALCITONIN
GENE-RELATED PEPTIDE
TYPE 1 RECEPTOR
FUSION PROTEIN

(Escherichia
coli;
Homo sapiens) 		PF02793
(HRM)
PF04901
(RAMP)
PF13416
(SBP_bac_8) 		6 ASN A  14
GLU A 155
TYR A 157
MET A 332
TRP A 342
ARG A 346
 MAL  A2201 (-4.6A)
MAL  A2201 (-3.7A)
MAL  A2201 (-3.9A)
MAL  A2201 ( 4.3A)
MAL  A2201 (-3.7A)
None
 0.88A 3jyrA-4rwfA:
61.9		 3jyrA-4rwfA:
61.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4rwf MALTOSE TRANSPORTER
SUBUNIT, RECEPTOR
ACTIVITY-MODIFYING
PROTEIN 2,
CALCITONIN
GENE-RELATED PEPTIDE
TYPE 1 RECEPTOR
FUSION PROTEIN

(Escherichia
coli;
Homo sapiens) 		PF02793
(HRM)
PF04901
(RAMP)
PF13416
(SBP_bac_8) 		6 ASN A  14
TRP A  64
GLU A 155
TYR A 157
MET A 332
TRP A 342
 MAL  A2201 (-4.6A)
MAL  A2201 (-4.3A)
MAL  A2201 (-3.7A)
MAL  A2201 (-3.9A)
MAL  A2201 ( 4.3A)
MAL  A2201 (-3.7A)
 0.17A 3jyrA-4rwfA:
61.9		 3jyrA-4rwfA:
61.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4tsm MALTOSE-BINDING
PROTEIN, PILIN
CHIMERA

(Clostridioides
difficile;
Escherichia
coli) 		PF13416
(SBP_bac_8) 		6 ASN A  12
TRP A  62
GLU A 153
TYR A 155
MET A 330
TRP A 340
 MTT  A1209 ( 4.7A)
MTT  A1209 (-4.3A)
MTT  A1209 (-3.2A)
MTT  A1209 (-3.8A)
MTT  A1209 ( 4.1A)
MTT  A1209 (-3.8A)
 0.30A 3jyrA-4tsmA:
60.8		 3jyrA-4tsmA:
66.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4tsm MALTOSE-BINDING
PROTEIN, PILIN
CHIMERA

(Clostridioides
difficile;
Escherichia
coli) 		PF13416
(SBP_bac_8) 		6 ASN A  12
TRP A  62
TYR A 155
MET A 330
TRP A 340
ARG A 344
 MTT  A1209 ( 4.7A)
MTT  A1209 (-4.3A)
MTT  A1209 (-3.8A)
MTT  A1209 ( 4.1A)
MTT  A1209 (-3.8A)
MTT  A1209 (-4.0A)
 0.55A 3jyrA-4tsmA:
60.8		 3jyrA-4tsmA:
66.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4wrn MALTOSE-BINDING
PERIPLASMIC
PROTEIN,UROMODULIN

(Escherichia
coli;
Homo sapiens) 		PF00100
(Zona_pellucida)
PF13416
(SBP_bac_8) 		7 ASN A  36
TRP A  86
GLU A 177
TYR A 179
MET A 354
TRP A 364
ARG A 368
 None
MAL  A 801 (-4.1A)
MAL  A 801 (-3.0A)
MAL  A 801 (-2.9A)
MAL  A 801 ( 3.8A)
MAL  A 801 (-3.0A)
None
 0.75A 3jyrA-4wrnA:
59.5		 3jyrA-4wrnA:
48.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4wvi MALTOSE-BINDING
PERIPLASMIC
PROTEIN,SIGNAL
PEPTIDASE IB

(Escherichia
coli;
Staphylococcus
aureus) 		PF00717
(Peptidase_S24)
PF13416
(SBP_bac_8) 		6 ASN A  18
TRP A  68
GLU A 159
TYR A 161
MET A 336
TRP A 346
 MAL  A 601 (-4.4A)
MAL  A 601 (-4.4A)
MAL  A 601 (-3.6A)
MAL  A 601 (-3.9A)
MAL  A 601 ( 4.3A)
MAL  A 601 (-3.7A)
 0.24A 3jyrA-4wviA:
61.6		 3jyrA-4wviA:
61.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xa2 MALTOSE-BINDING
PERIPLASMIC
PROTEIN,MBP-PILA: C

(Acinetobacter
baumannii;
Escherichia
coli) 		PF00114
(Pilin)
PF13416
(SBP_bac_8) 		6 ASN A  12
TRP A  62
GLU A 153
TYR A 155
MET A 330
TRP A 340
 MLR  A1201 ( 4.7A)
MLR  A1201 (-4.4A)
MLR  A1201 (-3.2A)
MLR  A1201 (-3.8A)
MLR  A1201 ( 4.4A)
MLR  A1201 (-4.1A)
 0.21A 3jyrA-4xa2A:
62.4		 3jyrA-4xa2A:
73.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xai MALTOSE-BINDING
PERIPLASMIC
PROTEIN,TAILLESS
ORTHOLOG

(Escherichia
coli;
Tribolium
castaneum) 		PF00104
(Hormone_recep)
PF13416
(SBP_bac_8) 		6 ASN A  14
TRP A  64
GLU A 155
TYR A 157
MET A 332
TRP A 342
 MAL  A1401 (-4.6A)
MAL  A1401 (-4.5A)
MAL  A1401 (-3.7A)
MAL  A1401 (-3.8A)
MAL  A1401 ( 4.4A)
MAL  A1401 (-3.7A)
 0.27A 3jyrA-4xaiA:
62.1		 3jyrA-4xaiA:
77.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xaj MALTOSE-BINDING
PERIPLASMIC
PROTEIN,NUCLEAR
RECEPTOR SUBFAMILY 2
GROUP E MEMBER 1

(Escherichia
coli;
Homo sapiens) 		PF00104
(Hormone_recep)
PF13416
(SBP_bac_8) 		6 ASN A  14
TRP A  64
GLU A 155
TYR A 157
MET A 332
TRP A 342
 MAL  A1900 (-4.6A)
MAL  A1900 (-4.0A)
MAL  A1900 (-4.5A)
MAL  A1900 (-4.2A)
MAL  A1900 ( 4.5A)
MAL  A1900 ( 4.0A)
 0.31A 3jyrA-4xajA:
61.9		 3jyrA-4xajA:
58.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5aza MALTOSE-BINDING
PERIPLASMIC
PROTEIN,OLIGOSACCHAR
YL TRANSFERASE STT3
SUBUNIT RELATED
PROTEIN

(Escherichia
coli;
Pyrococcus
furiosus) 		PF13416
(SBP_bac_8) 		6 ASN A  12
TRP A  62
GLU A 153
TYR A 155
MET A 330
TRP A 340
 MAL  A 901 ( 4.9A)
MAL  A 901 (-4.4A)
MAL  A 901 (-3.7A)
MAL  A 901 (-3.8A)
MAL  A 901 ( 4.4A)
MAL  A 901 (-3.6A)
 0.44A 3jyrA-5azaA:
58.0		 3jyrA-5azaA:
42.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5c7r FUSION PROTEIN OF
MALTOSE-BINDING
PERIPLASMIC PROTEIN
AND TYPE-3
ICE-STRUCTURING
PROTEIN HPLC 12

(Escherichia
coli;
Zoarces
americanus) 		PF01547
(SBP_bac_1) 		6 ASN A  12
TRP A  62
GLU A 153
TYR A 155
MET A 330
TRP A 340
 MLR  A 501 (-4.7A)
MLR  A 501 (-4.5A)
MLR  A 501 (-3.2A)
MLR  A 501 (-3.9A)
MLR  A 501 ( 4.3A)
MLR  A 501 (-4.0A)
 0.14A 3jyrA-5c7rA:
62.7		 3jyrA-5c7rA:
76.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5c7r FUSION PROTEIN OF
MALTOSE-BINDING
PERIPLASMIC PROTEIN
AND TYPE-3
ICE-STRUCTURING
PROTEIN HPLC 12

(Escherichia
coli;
Zoarces
americanus) 		PF01547
(SBP_bac_1) 		6 ASN A  12
TRP A  62
TYR A 155
MET A 330
TRP A 340
ARG A 344
 MLR  A 501 (-4.7A)
MLR  A 501 (-4.5A)
MLR  A 501 (-3.9A)
MLR  A 501 ( 4.3A)
MLR  A 501 (-4.0A)
None
 0.57A 3jyrA-5c7rA:
62.7		 3jyrA-5c7rA:
76.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5cfv MALTOSE-BINDING
PERIPLASMIC
PROTEIN,MALTOSE-BIND
ING PERIPLASMIC
PROTEIN,PILA FUSION
PROTEIN

(Acinetobacter
nosocomialis;
Escherichia
coli) 		PF00114
(Pilin)
PF01547
(SBP_bac_1) 		7 ASN A  12
TRP A  62
GLU A 153
TYR A 155
MET A 330
TRP A 340
ARG A 344
 MAL  A1201 (-4.5A)
MAL  A1201 (-4.4A)
MAL  A1201 (-3.6A)
MAL  A1201 (-3.9A)
MAL  A1201 (-4.3A)
MAL  A1201 (-3.7A)
None
 0.79A 3jyrA-5cfvA:
55.2		 3jyrA-5cfvA:
72.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5dfm MALTOSE-BINDING
PERIPLASMIC
PROTEIN,TELOMERASE-A
SSOCIATED PROTEIN 19

(Escherichia
coli;
Tetrahymena
thermophila) 		PF13416
(SBP_bac_8) 		6 ASN A  12
TRP A  62
GLU A 153
TYR A 155
MET A 330
TRP A 340
 SO4  A 602 (-3.5A)
MAL  A 601 (-4.3A)
MAL  A 601 ( 3.7A)
MAL  A 601 (-4.0A)
MAL  A 601 ( 4.3A)
MAL  A 601 (-3.6A)
 0.51A 3jyrA-5dfmA:
60.6		 3jyrA-5dfmA:
69.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5dis MALTOSE-BINDING
PERIPLASMIC
PROTEIN,NUCLEAR PORE
COMPLEX PROTEIN
NUP214

(Escherichia
coli;
Homo sapiens) 		PF13416
(SBP_bac_8) 		5 ASN D  12
TRP D  62
GLU D 153
MET D 330
ARG D 344
 None
 0.98A 3jyrA-5disD:
43.5		 3jyrA-5disD:
73.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5edu MALTOSE-BINDING
PERIPLASMIC PROTEIN,
HISTONE DEACETYLASE
6 CHIMERA

(Escherichia
coli;
Homo sapiens) 		no annotation 7 ASN B 120
TRP B 170
GLU B 261
TYR B 263
MET B 438
TRP B 448
ARG B 452
 MAL  B2505 (-4.4A)
MAL  B2505 (-4.3A)
MAL  B2505 (-3.4A)
MAL  B2505 (-4.1A)
MAL  B2505 ( 4.5A)
MAL  B2505 (-3.8A)
None
 0.36A 3jyrA-5eduB:
60.0		 3jyrA-5eduB:
47.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5fsg MALTOSE-BINDING
PERIPLASMIC PROTEIN,
HANTAVIRUS
NUCLEOPROTEIN

(Hantaan
orthohantavirus) 		PF00846
(Hanta_nucleocap)
PF13416
(SBP_bac_8) 		7 ASN A-360
TRP A-310
GLU A-219
TYR A-217
MET A -42
TRP A -32
ARG A -28
 MTT  A1431 (-4.2A)
MTT  A1431 (-4.1A)
MTT  A1431 (-3.4A)
MTT  A1431 (-3.6A)
MTT  A1431 (-3.7A)
MTT  A1431 (-3.2A)
MTT  A1431 (-2.9A)
 0.43A 3jyrA-5fsgA:
58.1		 3jyrA-5fsgA:
62.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5gpp MALTOSE-BINDING
PERIPLASMIC
PROTEIN,APOPTOSIS-AS
SOCIATED SPECK-LIKE
PROTEIN CONTAINING A
CARD

(Danio rerio;
Escherichia
coli) 		PF02758
(PYRIN)
PF13416
(SBP_bac_8) 		7 ASN A  13
TRP A  63
GLU A 154
TYR A 156
MET A 331
TRP A 341
ARG A 345
 MAL  A 501 ( 4.9A)
MAL  A 501 (-4.8A)
MAL  A 501 (-3.8A)
MAL  A 501 (-4.2A)
MAL  A 501 ( 4.6A)
MAL  A 501 ( 4.0A)
None
 0.60A 3jyrA-5gppA:
44.2		 3jyrA-5gppA:
78.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5gpq MALTOSE-BINDING
PERIPLASMIC
PROTEIN,APOPTOSIS-AS
SOCIATED SPECK-LIKE
PROTEIN CONTAINING A
CARD

(Danio rerio;
Escherichia
coli) 		PF00619
(CARD)
PF13416
(SBP_bac_8) 		6 ASN A  13
TRP A  63
GLU A 154
TYR A 156
MET A 331
TRP A 341
 MAL  A 501 (-4.4A)
MAL  A 501 (-4.4A)
MAL  A 501 (-3.7A)
MAL  A 501 (-3.9A)
MAL  A 501 ( 4.4A)
MAL  A 501 (-3.7A)
 0.17A 3jyrA-5gpqA:
62.4		 3jyrA-5gpqA:
78.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5gpq MALTOSE-BINDING
PERIPLASMIC
PROTEIN,APOPTOSIS-AS
SOCIATED SPECK-LIKE
PROTEIN CONTAINING A
CARD

(Danio rerio;
Escherichia
coli) 		PF00619
(CARD)
PF13416
(SBP_bac_8) 		6 ASN A  13
TRP A  63
TYR A 156
MET A 331
TRP A 341
ARG A 345
 MAL  A 501 (-4.4A)
MAL  A 501 (-4.4A)
MAL  A 501 (-3.9A)
MAL  A 501 ( 4.4A)
MAL  A 501 (-3.7A)
None
 0.58A 3jyrA-5gpqA:
62.4		 3jyrA-5gpqA:
78.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5gxv MALTOSE-BINDING
PERIPLASMIC
PROTEIN,PIGG

(Escherichia
coli;
Serratia) 		PF13416
(SBP_bac_8) 		4 GLU A 155
TYR A 157
MET A 332
TRP A 342
 None
 0.82A 3jyrA-5gxvA:
35.6		 3jyrA-5gxvA:
85.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5h7n NLRP12-PYD WITH MBP
TAG

(Homo sapiens) 		PF02758
(PYRIN)
PF13416
(SBP_bac_8) 		6 ASN A  13
TRP A  63
GLU A 154
TYR A 156
MET A 331
TRP A 341
 MTT  A 501 ( 4.8A)
MTT  A 501 (-4.4A)
MTT  A 501 (-3.5A)
MTT  A 501 (-3.9A)
MTT  A 501 ( 4.3A)
MTT  A 501 (-3.9A)
 0.09A 3jyrA-5h7nA:
59.2		 3jyrA-5h7nA:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5h7n NLRP12-PYD WITH MBP
TAG

(Homo sapiens) 		PF02758
(PYRIN)
PF13416
(SBP_bac_8) 		6 ASN A  13
TRP A  63
TYR A 156
MET A 331
TRP A 341
ARG A 345
 MTT  A 501 ( 4.8A)
MTT  A 501 (-4.4A)
MTT  A 501 (-3.9A)
MTT  A 501 ( 4.3A)
MTT  A 501 (-3.9A)
MTT  A 501 (-3.9A)
 0.57A 3jyrA-5h7nA:
59.2		 3jyrA-5h7nA:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5hz7 COMP

(Neisseria
meningitidis) 		PF13416
(SBP_bac_8)
PF16732
(ComP_DUS) 		6 ASN A  13
TRP A  63
GLU A 154
TYR A 156
MET A 331
TRP A 341
 MLR  A 501 ( 4.6A)
MLR  A 501 (-4.0A)
MLR  A 501 (-2.6A)
MLR  A 501 (-2.8A)
MLR  A 501 (-3.7A)
MLR  A 501 (-3.1A)
 0.18A 3jyrA-5hz7A:
62.8		 3jyrA-5hz7A:
66.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5hz7 COMP

(Neisseria
meningitidis) 		PF13416
(SBP_bac_8)
PF16732
(ComP_DUS) 		6 ASN A  13
TRP A  63
TYR A 156
MET A 331
TRP A 341
ARG A 345
 MLR  A 501 ( 4.6A)
MLR  A 501 (-4.0A)
MLR  A 501 (-2.8A)
MLR  A 501 (-3.7A)
MLR  A 501 (-3.1A)
BGC  A 504 ( 3.9A)
 0.60A 3jyrA-5hz7A:
62.8		 3jyrA-5hz7A:
66.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5hzv MALTOSE-BINDING
PERIPLASMIC
PROTEIN,ENDOGLIN

(Escherichia
coli;
Homo sapiens) 		PF00100
(Zona_pellucida)
PF13416
(SBP_bac_8) 		7 ASN A 379
TRP A 429
GLU A 520
TYR A 522
MET A 697
TRP A 707
ARG A 711
 MAL  A1001 (-4.1A)
MAL  A1001 (-4.3A)
MAL  A1001 (-3.3A)
MAL  A1001 (-4.0A)
MAL  A1001 ( 4.4A)
MAL  A1001 (-4.0A)
None
 0.72A 3jyrA-5hzvA:
61.5		 3jyrA-5hzvA:
81.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5hzw MALTOSE-BINDING
PERIPLASMIC
PROTEIN,ENDOGLIN

(Escherichia
coli;
Homo sapiens) 		PF13416
(SBP_bac_8) 		6 ASN A  67
GLU A 208
TYR A 210
MET A 385
TRP A 395
ARG A 399
 MAL  A 803 ( 4.4A)
MAL  A 803 (-3.5A)
MAL  A 803 (-3.0A)
MAL  A 803 ( 3.5A)
MAL  A 803 ( 3.0A)
None
 0.82A 3jyrA-5hzwA:
59.8		 3jyrA-5hzwA:
58.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5hzw MALTOSE-BINDING
PERIPLASMIC
PROTEIN,ENDOGLIN

(Escherichia
coli;
Homo sapiens) 		PF13416
(SBP_bac_8) 		6 ASN A  67
TRP A 117
GLU A 208
TYR A 210
MET A 385
TRP A 395
 MAL  A 803 ( 4.4A)
MAL  A 803 (-3.6A)
MAL  A 803 (-3.5A)
MAL  A 803 (-3.0A)
MAL  A 803 ( 3.5A)
MAL  A 803 ( 3.0A)
 0.43A 3jyrA-5hzwA:
59.8		 3jyrA-5hzwA:
58.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ii5 MALTOSE-BINDING
PERIPLASMIC
PROTEIN,VITELLINE
ENVELOPE SPERM LYSIN
RECEPTOR

(Escherichia
coli;
Haliotis
rufescens) 		PF11386
(VERL)
PF13416
(SBP_bac_8) 		6 ASN A3679
TRP A3729
GLU A3820
TYR A3822
MET A3997
TRP A4007
 MAL  A4201 (-4.6A)
MAL  A4201 (-3.7A)
MAL  A4201 (-3.2A)
MAL  A4201 (-2.8A)
MAL  A4201 ( 3.5A)
MAL  A4201 (-2.6A)
 0.20A 3jyrA-5ii5A:
37.7		 3jyrA-5ii5A:
68.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5iic MALTOSE-BINDING
PERIPLASMIC
PROTEIN,VITELLINE
ENVELOPE SPERM LYSIN
RECEPTOR

(Escherichia
coli;
Haliotis
rufescens) 		PF11386
(VERL)
PF13416
(SBP_bac_8) 		6 ASN A3981
TRP A4031
GLU A4122
TYR A4124
MET A4299
TRP A4309
 MAL  A4501 (-4.0A)
MAL  A4501 (-3.8A)
MAL  A4501 (-3.8A)
MAL  A4501 (-3.0A)
MAL  A4501 ( 3.4A)
MAL  A4501 ( 3.0A)
 0.35A 3jyrA-5iicA:
56.3		 3jyrA-5iicA:
72.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5jj4 MALTOSE-BINDING
PERIPLASMIC
PROTEIN,SINGLE-STRAN
DED DNA CYTOSINE
DEAMINASE

(Escherichia
coli;
Homo sapiens) 		no annotation 7 ASN C  12
TRP C  62
GLU C 153
TYR C 155
MET C 330
TRP C 340
ARG C 344
 MTT  C1203 ( 4.8A)
MTT  C1203 (-4.1A)
MTT  C1203 (-3.5A)
MTT  C1203 (-3.9A)
MTT  C1203 (-4.2A)
MTT  C1203 (-4.0A)
MTT  C1203 (-4.1A)
 0.34A 3jyrA-5jj4C:
61.4		 3jyrA-5jj4C:
72.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5jon MALTOSE-BINDING
PERIPLASMIC
PROTEIN,POTASSIUM/SO
DIUM
HYPERPOLARIZATION-AC
TIVATED CYCLIC
NUCLEOTIDE-GATED
CHANNEL 2

(Escherichia
coli;
Mus musculus) 		PF00027
(cNMP_binding)
PF13416
(SBP_bac_8) 		6 ASN A-357
TRP A-307
GLU A-216
TYR A-214
MET A -39
TRP A -29
 MAL  A 701 (-4.5A)
MAL  A 701 (-4.3A)
MAL  A 701 (-3.6A)
MAL  A 701 (-3.9A)
MAL  A 701 ( 4.3A)
MAL  A 701 (-3.7A)
 0.25A 3jyrA-5jonA:
62.0		 3jyrA-5jonA:
65.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5k94 MALTOSE-BINDING
PERIPLASMIC
PROTEIN,PROTEIN
TRANSLOCASE SUBUNIT
SECA,MALTOSE-BINDING
PERIPLASMIC PROTEIN

(Escherichia
coli) 		PF01043
(SecA_PP_bind)
PF01547
(SBP_bac_1)
PF13416
(SBP_bac_8) 		4 GLU A 153
TYR A 155
MET A1330
TRP A1340
 B3P  A1401 (-4.0A)
B3P  A1401 ( 4.1A)
None
None
 0.49A 3jyrA-5k94A:
45.5		 3jyrA-5k94A:
66.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5osq MALTOSE-BINDING
PERIPLASMIC
PROTEIN,ZONA
PELLUCIDA
SPERM-BINDING
PROTEIN 3

(Escherichia
coli;
Mus musculus) 		PF00100
(Zona_pellucida)
PF13416
(SBP_bac_8) 		6 ASN A  13
TRP A  63
GLU A 154
TYR A 156
MET A 331
TRP A 341
 MAL  A 501 (-4.3A)
MAL  A 501 (-3.8A)
MAL  A 501 (-3.4A)
MAL  A 501 (-2.7A)
MAL  A 501 ( 3.5A)
MAL  A 501 (-2.6A)
 0.25A 3jyrA-5osqA:
56.7		 3jyrA-5osqA:
75.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t03 MALTOSE BINDING
PROTEIN - HEPARAN
SULFATE
6-O-SULFOTRANSFERASE
ISOFORM 3 FUSION
PROTEIN

(Danio rerio;
Escherichia
coli) 		PF03567
(Sulfotransfer_2)
PF13416
(SBP_bac_8) 		6 ASN A  12
TRP A  62
GLU A 153
TYR A 155
MET A 330
TRP A 340
 GLC  A1412 ( 4.7A)
GLC  A1411 ( 4.3A)
GLC  A1410 ( 3.0A)
GLC  A1412 ( 3.8A)
GLC  A1411 (-4.2A)
GLC  A1411 ( 3.8A)
 0.20A 3jyrA-5t03A:
62.7		 3jyrA-5t03A:
56.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t03 MALTOSE BINDING
PROTEIN - HEPARAN
SULFATE
6-O-SULFOTRANSFERASE
ISOFORM 3 FUSION
PROTEIN

(Danio rerio;
Escherichia
coli) 		PF03567
(Sulfotransfer_2)
PF13416
(SBP_bac_8) 		6 ASN A  12
TRP A  62
TYR A 155
MET A 330
TRP A 340
ARG A 344
 GLC  A1412 ( 4.7A)
GLC  A1411 ( 4.3A)
GLC  A1412 ( 3.8A)
GLC  A1411 (-4.2A)
GLC  A1411 ( 3.8A)
GLC  A1409 (-3.9A)
 0.62A 3jyrA-5t03A:
62.7		 3jyrA-5t03A:
56.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5tj2 SUGAR ABC
TRANSPORTER
SUBSTRATE-BINDING
PROTEIN,GASDERMIN-B
FUSION PROTEIN

(Escherichia
coli;
Homo sapiens) 		PF04598
(Gasdermin)
PF13416
(SBP_bac_8) 		6 ASN A  12
TRP A  62
GLU A 153
TYR A 155
MET A 330
TRP A 340
 MAL  A1501 (-4.3A)
MAL  A1501 (-4.4A)
MAL  A1501 (-3.5A)
MAL  A1501 (-3.9A)
MAL  A1501 ( 4.5A)
MAL  A1501 (-3.8A)
 0.14A 3jyrA-5tj2A:
61.5		 3jyrA-5tj2A:
85.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ttd MALTOSE-BINDING
PERIPLASMIC
PROTEIN,PILIN
ISOPEPTIDE LINKAGE
DOMAIN PROTEIN

(Escherichia
coli;
Streptococcus
pyogenes) 		PF12892
(FctA)
PF13416
(SBP_bac_8) 		6 ASN A  18
TRP A  68
GLU A 159
TYR A 161
MET A 336
TRP A 346
 MLR  A 501 (-4.2A)
MLR  A 501 (-4.4A)
MLR  A 501 (-2.8A)
MLR  A 501 (-3.9A)
MLR  A 501 ( 4.4A)
MLR  A 501 (-3.9A)
 0.22A 3jyrA-5ttdA:
61.3		 3jyrA-5ttdA:
66.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ttd MALTOSE-BINDING
PERIPLASMIC
PROTEIN,PILIN
ISOPEPTIDE LINKAGE
DOMAIN PROTEIN

(Escherichia
coli;
Streptococcus
pyogenes) 		PF12892
(FctA)
PF13416
(SBP_bac_8) 		6 ASN A  18
TRP A  68
TYR A 161
MET A 336
TRP A 346
ARG A 350
 MLR  A 501 (-4.2A)
MLR  A 501 (-4.4A)
MLR  A 501 (-3.9A)
MLR  A 501 ( 4.4A)
MLR  A 501 (-3.9A)
MLR  A 501 (-4.8A)
 0.58A 3jyrA-5ttdA:
61.3		 3jyrA-5ttdA:
66.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5v6y MALTOSE-BINDING
PERIPLASMIC
PROTEIN,RECEPTOR
ACTIVITY-MODIFYING
PROTEIN 1,CALCITONIN
GENE-RELATED PEPTIDE
TYPE 1 RECEPTOR

(Escherichia
coli;
Homo sapiens) 		no annotation 6 ASN A  14
TRP A  64
GLU A 155
TYR A 157
MET A 332
TRP A 342
 MAL  A2201 (-4.1A)
MAL  A2201 (-4.5A)
MAL  A2201 (-3.7A)
MAL  A2201 (-3.9A)
MAL  A2201 ( 4.2A)
MAL  A2201 (-3.7A)
 0.28A 3jyrA-5v6yA:
61.8		 3jyrA-5v6yA:
75.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5wq6 MBP TAGGED HMNDA-PYD

(Homo sapiens) 		PF02758
(PYRIN)
PF13416
(SBP_bac_8) 		6 ASN A  13
TRP A  63
GLU A 154
TYR A 156
MET A 331
TRP A 341
 EDO  A 503 (-3.4A)
MAL  A 501 (-4.5A)
MAL  A 501 (-3.7A)
MAL  A 501 (-3.8A)
MAL  A 501 (-4.4A)
MAL  A 501 (-3.7A)
 0.18A 3jyrA-5wq6A:
63.3		 3jyrA-5wq6A:
76.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5z0r EXTRACELLULAR
SOLUTE-BINDING
PROTEIN FAMILY
1,VIRAL GENOME
PROTEIN

(Escherichia
coli) 		no annotation 7 ASN A  13
TRP A  63
GLU A 154
TYR A 156
MET A 331
TRP A 341
ARG A 345
 MAL  A 501 ( 3.7A)
MAL  A 501 (-3.5A)
MAL  A 501 (-3.6A)
MAL  A 501 (-2.9A)
MAL  A 501 ( 3.7A)
MAL  A 501 (-2.7A)
None
 0.70A 3jyrA-5z0rA:
37.2		 3jyrA-5z0rA:
60.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6anv ANTI-CRISPR PROTEIN
ACRF1 FUSED WITH
C-TERMINAL MBP TAG

(Escherichia
coli;
Pseudomonas
phage JBD30) 		no annotation 7 ASN A  92
TRP A 142
GLU A 233
TYR A 235
MET A 410
TRP A 420
ARG A 424
 MTT  A 501 (-4.6A)
MTT  A 501 (-4.1A)
MTT  A 501 (-3.2A)
MTT  A 501 (-3.8A)
MTT  A 501 ( 4.1A)
MTT  A 501 (-3.8A)
MTT  A 501 (-4.1A)
 0.45A 3jyrA-6anvA:
62.4		 3jyrA-6anvA:
80.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6dm8 -

(-) 		no annotation 6 ASN A-203
TRP A-153
GLU A -62
TYR A -60
MET A 115
TRP A 125
 MAL  A 402 ( 4.7A)
MAL  A 402 (-4.1A)
MAL  A 402 (-3.7A)
MAL  A 402 (-4.1A)
MAL  A 402 ( 4.8A)
MAL  A 402 (-3.7A)
 0.48A 3jyrA-6dm8A:
60.4		 3jyrA-6dm8A:
undetectable